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1. Introduction 
1.1 The life and death of lymphocytes 
B and T lymphocytes are the central cells of the adaptive immune system. To 
keep the right balance between the life and death of lymphocytes is a key 
mechanism for maintaining homeostasis of the immune system as well as for 
maintaining its proper function. Changes in this fine-tuned balance will lead to 
the generation of autoimmune diseases, to the appearance of leukemias and 
lymphomas, or to immune deficiencies which affect millions of people 
worldwide.  
1.1.1 Maturation and activation of lymphocytes through crucial signaling 
pathways 
Maturation and activation of lymphocytes are driven by a series of signaling 
pathways which lead to the activation (or inactivation) of a large number of 
genes. Lymphocytes derive from lymphocyte progenitor cells which are 
generated from bone marrow stem cell. These hematopoietic progenitor cells 
develop in bone marrow (B cells) or in thymus (T cells), and, finally, mature to 
populations of lymphocytes in peripheral lymphoid tissues, such as in spleen 
and lymph nodes. The genes which are switched on during development of 
lymphocytes encode transcription factors, such as the NFAT and NF-kB 
factors (Kumar et al., 2005; Siebenlist et al., 2005), components of the pre-T 
and pre-B antigen receptor complexes (Nemazee, 2006; Wang and Clark, 
2003), enzymes, such as ZAP-70 and calcineurin (Clipstone and Crabtree, 
1992), adapter proteins, such as Grb2 (Peterson et al., 1998), and many other 
proteins which are predominantly involved in signal transduction in lymphocyte 
precursor cells (Engel and Murre, 2001). Thereby, lymphocytes transit from 
one stage to the next, and key events in these differentiation processes are 
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designated as checkpoints. Naturally occurring mutations, or gene-targeting of 
such `critical` genes can lead to complete blocks in lymphocyte maturation at 
certain stages and/or can result in the generation of (human) 
immunodeficiency, such as in the X-linked severe combined immunodeficiency 
disease in humans which is due to a natural mutation of IL-2 receptor common 
γ chain (Noguchi et al., 1993).  
 Among the events of lymphocyte development, expression of immune T 
and B cell receptors (TCR, BCR) and of their signal transduction components 
are crucially involved in the maturation of lymphocytes (Su and Rawlings, 
2002). Such lymphocytes expressing functional receptors are “positively” 
selected to survive, while T and B cells without expression of functional 
receptors die by apoptosis, such as thymocytes without a functional TCR at the 
double-positive stage of thymocyte development. These positive and negative 
selection processes of thymocytes (and B cells) “provide” surviving immune 
cells with a useful repertoire of receptors. Those cells having low-affinity 
receptors directed against self antigens proliferate and proceed to mature after 
positive selection, whereas the cells having high-affinity receptors die by 
apoptosis by negative selection (Goldrath and Bevan, 1999). Most important, 
multiple checkpoints ensure that only cells with proper immunoreceptors 
mature to be effector lymphocytes or, later on, memory cells (Miosge and 
Zamoyska, 2007; Roth and DeFranco, 1995).   
 Of the signaling pathways emerging from the TCR and BCR complexes, 
the NFAT and NF-kB signaling cascades are in the centre of signaling events 
controlling lymphocyte fate (Crabtree and Olson, 2002; Miosge and Zamoyska, 
2007; Wang and Clark, 2003). The members of these two transcription factor 
families regulate the expression of numerous genes controlling the activation, 
differentiation and apoptosis of lymphocytes (Bours et al., 1992; Macian, 2005; 
Serfling et al., 2007). How do they contribute to shape and to activate the 
immune system? Previous studies indicate that different inputs determine the 
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way how they are activated. Many other important factors are involved in the 
NFAT and NF-kB signaling pathways and contribute to the final output. Thus, 
the MAGUK scaffold protein Dlgh1 was identified to ‘orchestrate’ TCR 
signaling which coordinates alternative p38 kinase activation, directing T cell 
receptor signals towards NFAT but not to NF-kB activation (Round et al., 
2007). On the other hand, in inflammated tissues, both NFAT and NF-kB 
pathways are suppressed by the Foxhead transcription factor Foxd1 (Lin and 
Peng, 2006). 
  
1.1.2 Apoptosis of lymphocytes: the functional role of Nfatc1 
One central event of processes mentioned above is apoptosis. In activation-
induced apoptosis (also know as `Activation Induced Cell Death`, AICD) 
activation is initiated at the receptors of B or T lymphocytes by antigens, and 
these cells are often ignored by survival signals. AICD involves various 
signaling pathways – including caspase cascades - and results in death of 
affected cells and clearance by macrophages. Its morphological features are 
blebbed membranes, shrunken nuclei and DNA cut to small pieces, but no 
inflammation of affected cells occurs distinguishing apoptosis from necrosis 
(Rathmell and Thompson, 2002; Strasser and Bouillet, 2003). Thereby, 
apoptosis helps to shape the repertoire of B and T cell receptors, to terminate 
immune responses and to sustain the homeostasis of the immune system. 
 NFATs play diverse functions in apoptosis. When associated with p300 
upon stimulation by ET-1, NFAT factors can exert an anti-apoptotic activity 
(Kawamura et al., 2004; Van Sant et al., 2007), while in other situations NFATs 
activate AICD via Fas(CD95) (Holtz-Heppelmann et al., 1998; Latinis et al., 
1997; Santini et al., 2001). We have previously observed that NFATc2 and c3 
support the apoptosis of effector T cells (Chuvpilo et al., 2002) and, therefore, 
exert a pro-apoptotic function in T lymphocytes. In contrast, in these studies 
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the function of NFATc1/aA, the strongly induced short isoform of NFATc1, 
remained unclear. The experiments presented in this doctoral thesis contribute 
to the question which role this particular isoform exerts in the control of AICD in 
lymphocytes.  
1.2 NFATc1: Structure and Function of its Isoforms 
1.2.1 NFAT family members 
Since the cloning of the first NFAT cDNA in 1993 (McCarthy et al., 1993), five 
members of family of nuclear factor of activated T cell (NFAT) proteins have 
been discovered (Macian, 2005; Serfling et al., 2000; Shaw et al., 1988). Their 
nomenclature and several of their properties are displayed in Table 1-1 (from: 
http://www.genenames.org/cgi-bin/hgnc_search.pl).  
Table 1-1 Nomenclature of NFAT Family by HUGO Gene Nomenclature 
Committee 
Approved Gene 
Symbol 
(for human) 
Approved Gene Name Location Sequence Accession IDs Aliases 
NFAT5 nuclear factor of activated T-cells 5, tonicity-responsive factor 16q23.1 
AF134870 
NM_138714 
ENSG00000102908 
TONEBP, KIAA0827, 
NFATL1, OREBP, NFATZ, 
NF-AT5 
NFATC1  nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1  18q23  
U08015 
NM_172390 
ENSG00000131196 
NF-ATC, NFATc 
NFATC2  nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2  20q13.2  
U43342, U43341 
NM_012340 
ENSG00000101096  
NF-ATP, NFATp 
NFATC3  nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3  16q22  
L41067 
NM_004555 
ENSG00000072736  
NFAT4, NFATX 
NFATC4 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 14q11.2 
BC053855 
NM_004554 
ENSG00000100968 
NFAT3 
 
1.2.2 The structure of the NFATC1 gene and its 6 protein isoforms 
The murine and human Nfatc1 genes consist of 11 exons which are distributed 
over more than 150 kB DNA. The expression of the Nfatc1 genes is controlled 
by two promoters and two polyadenylation (pA) sites and alternative splicing 
events (Figure 1-1-A)(Serfling et al., 2006). The promoter 1 P1 is located just 
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in front of exon1 and promoter 2 (P2) in front of exon 2. The polyadenylation 
site pA1 is located proximal from pA2 which corresponds to the distal polyA 
site of the gene. P1 and P2 direct the synthesis of three different RNAs, 
respectively. P1 transcripts start at exon 1 with a corresponding α peptide of 
42 amino acids (aa) at its N-terminus while P2 transcripts start at exon 2 with a 
β peptide of 29 aa (Figure 1-1-B) (Park et al., 1996; Sherman et al., 1999). The 
length of C-terminal peptide in of A ,B and C isoforms is 19, 128 and 246 aa, 
respectively (Chuvpilo et al., 1999).  
 The long isoforms of NFATc1/ βB and βC are the most prominent 
NFATc1 proteins in resting lymphocytes. Their transcription starts from the P2 
promoter, the transcript is spliced from exon 2 to exon 3 and ends at the distal 
polyadenylation motif pA2. In addition, there is an alternative splicing event at 
the exon 10 which leads to the generation of the somewhat shorter 
NFATc1/ßB, compared to NFATc1/ßC. In contrast, transcription of 
NFATc1/ αΑ  - due to the highly inducible activity of P1 promoter -  is strongly 
induced (up to 15-20 fold) upon stimulation, spliced from exon 1 to exon 2, and 
ends at the proximal polyadenylation motif pA1 (Chuvpilo et al., 1999). The 
enriched binding of multiple inducible transcription factors, including NFAT 
itself, such as NF-κΒ, CREB, Fos and ATF-2 in P1, but not in P2, contributes 
to the difference in induction between P1 and P2 activities (Figure 1-1-C). 
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Figure 1- The structure of the Nfatc1 gene and its expression into 6 
RNA isoforms (from Chuvpilo et al., 2002, modified)). (A) A scheme of 
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structure and expression of the Nfatc1 gene. (B) The activity of the 
constitutive promoter P2 leads to the transcription of exon 2, splicing to 
exon 3 and the generation of three β isoforms. Upon activation of 
lymphocytes, the promoter activity switches from P2 to P1, and exon 1 
is transcribed and spliced to exon 3, resulting in the generation of α 
isoforms. Optimal induction conditions facilitate the predominant 
synthesis of NFATc1/αΑ (red) by the use of the proximal polyA site pA1. 
Unlike the distal polyA site pA2, pA1 is not conserved between mouse 
and human. Thereby NFATc1/αΑ lacks the C-terminal transactivation 
domain TAD-B. (C) The binding sites for transcription factors in 
promoter P1.  
 
1.3 Current problems: NFATc1function and the goal of this 
study 
NFATc1-deficient mice bearing a completely disrupted Nfatc1 gene die of 
circulatory failure in uterus. Therefore, it is impossible to study NFATc1 
function in differentiated organs and cells (de la Pompa et al., 1998). Thus, 
generation of mice for the conditional knockout of NFATc1 is necessary for the 
analysis of organ and cell type specific function of NFATc1 (Kondo et al., 
2003). However, as I will describe in this thesis, the mouse ES cell knockout 
strategy is very time consuming and can lead to failures in the germ line 
transmission of manipulated ES cells. Therefore, in collaboration with Dr. 
Eisaku Kondo (Univ. Okayama, Japan), we also used in our laboratory an 
alternative system for studying NFATc1 function, i.e. the system of chicken 
DT40 B cells (Lahti, 1999). Chicken DT40 B lymphoma cells are a useful 
system to inactivate eukaryotic genes and, therefore, to generate a loss of 
function mutations in somatic cells. In these cells, homologous recombination 
takes place at very high frequencies. In addition, these cells express B cell 
receptors, and AICD can easily be induced by triggering these cells through 
their BCRs. Therefore, these cells can be used to knock out candidate genes 
which are essentially involved in the control of apoptotic processes. By using 
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cDNA constructs expressing proteins with mutations or deletions, e.g. from 
human, these cells can also be used to delineate functional domains. 
 In our study, the murine ES cell gene targeting and DT40 B cell systems 
were used in parallel to disrupt the Nfatc1 gene. In particular, we wanted to 
study the function of individual 6 Nfatc1 isoforms, and among those the 
function of highly inducible short isoform Nfatc1/αΑ.    
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2. MATERIALS AND METHODS  
  
2.1 Materials  
2.1.1 General materials  
96 well qPCR plates,     ABgene  
Cell strainer (70µm)     Falcon 
Cryotubes 2 ml     Greiner bio-one  
Disposable needles, cuvette and syringes  Hartenstein  
Glasswares      Schott  
Nitrocellulose membrane    Schleicher & Schuell  
Parafilm      Hartenstein  
Pipette tipps      Eppendorf  
Pipettes      Sarstedt  
Polypropylene tubes     Greiner bio-one, Nunc  
Sterile fiters      Schleicher & Schuell  
Tissue culture dishes     Grainer bio-one, Falcon  
Tissue culture flasks     Greiner bio-one  
Tissue culture plates     Grainer-one, Falcon  
Tubes       Eppendorf  
Whatmann paper     Schleicher & Schuell  
X-ray film      Kodak  
2.1.2 Chemicals  
2-mercaptoethanol     Carl Roth  
2-propanol      Carl Roth  
Acetic acid      Carl Roth  
Acrylamid solutions      Carl Roth  
Agar         Carl Roth  
Agarose          Sigma-Aldrich  
Ampicillin        Hoechst  
APS         Merck  
Boric acid        Merck  
Bromophenol blue      Merck 
ß-mercaptoethanol      Carl Roth  
Calcium chloride       Carl Roth  
Chloroform        Carl Roth  
Coomassie brilliant blue R-250    Roche   
Cyclohexamide       Sigma  
Cyclosporin       Novartis Pharma  
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DEPC                         Carl Roth  
Disodium hydrogen phosphate   Merck 
DMEM       Gibco BRL  
DMSO       Carl Roth  
dNTPs       MBI-Fermentas  
DTT          Carl Roth  
ECL Chemiluminescence Kit   Amersham   
EDTA       Carl Roth  
EGTA       Carl Roth  
Ethanol       Carl Roth  
Ethium bromide      Carl Roth  
FCS                 Gibco BRL  
Formaldehyde      Carl Roth  
Gel extraction kit      Qiagen, Genomed  
Glutathione sepharose     Sigma-Aldrich  
Glycerol       Carl Roth  
Glycin       Merck   
Hepes       Carl Roth  
Hydrochloric acid     Merck  
Ionomycin       Aldrich  
IPTG        Boehringer-Ingelheim  
Isoamyl alcohol      Carl Roth  
L-glutamine       Gibco BRL  
Leupeptin hydrochloride    Gibco BRL  
L-glutamine      Serva  
L-glutathione [Mr: 307,3]    Sigma-Aldrich  
Lithium chloride [LiCl]     Saliter  
Milk powder      Sigma-Aldrich 
Low fat skimmed milk      Saliter  
Magnesium chloride      Carl Roth  
Methanol         Carl Roth  
Phenol          Carl Roth  
Plasmid DNA purification kit     Genomed  
PMSF       Serva  
Poly dI·dC       Sigma-Aldrich  
Potassium acetate      Carl Roth  
Potassium chloride      Sigma-Aldrich  
Potassium chloride     Carl Roth  
Potassium dihydrogen phosphate   Sigma-Aldrich  
Protein A/G sepharose    Santa Cruz  
Protein assay solution     Bio-Rad  
Protease inhibitor tablet (complete mini)  Santa Cruz  
Radioactive nucleotides    Amersham Pharma  
RPMI1640       Gibco BRL  
SB203580       Calbiochem  
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SDS        Carl Roth  
Sephadex G-50      Amersham Pharmacia  
Sodium acetate      Merck  
Sodium azide      Merck  
Sodium carbonate     Carl Roth  
Sodium chloride      Carl Roth  
Sodium hydrogen phosphate   Merck  
Sodium hydroxide        Carl Roth  
Sodium pyruvate      Gibco BRL  
SP600125       Calbiochem  
Streptomycin      Carl Roth  
TPA        Sigma Aldrich  
Tris        Carl Roth  
Triton X-100       Sigma Aldrich  
Trizol reagent      Invitrogen  
Trypan blue      Gibco BRL  
Tween-20       Carl Roth  
Western blotting substrate (Lumi-light)  Pierce  
2.1.3 Instruments  
Autoclave               Stiefenhofer  
DNA sequencer 373A     Perkin Elmer  
FACSCalibur      BD biosciences   
Gel camera      Stratagene  
Gel documentation system    Herolab  
Gel dryer       H.Hölzel  
GenePulser®II electroporation system  Bio-Rad  
Haemocytometer     Brand  
Heating       Hartenstain  
Humidified tissue culture incubator  Nuaire US  
Ice machines      Genheimer  
Incubator       Mytron  
Intensifying screen     DuPont  
Labsonic U      B.Braun  
Laminar hoods      Heraeus  
Light microscope     Olympus 
Liquid nitrogen tank                         Tec-lab  
Microcentrifuge      Eppendorf 
Multichannel pipette     Eppendorf  
Multi dispenser pipette     Eppendorf  
pH meter       Ingold  
Phosphorimager      Molecular Dynamics  
Power supply      Amersham Pharmacia  
Quartz cuvette      Hellma  
Real-Time PCR machine    ABI Prism 7000  
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Refrigerators       Privilege, Bosch, Heraeus  
Rotors                   Beckman  
SDS-PAGE apparatus      BioRad  
Shaking incubator      Hartenstein  
Spectrophotometer      Amsham Pharmacia  
Thermal cycler       MWG  
UV lamp (UVT-20M)      Herolab  
Varifuge        Hartenstain  
Water bath        Hartenstain  
Water filtration unit      Milipore  
Western blot apparatus      Hoefer, BioRad  
  
2.1.4 Kits  
First Strand cDNA Synthesis Kit    MBI Fermentas  
NucleoBond®         Macherey-Nagel  
LookOut™ Products for Mycoplasma Screening Sigma 
Long PCR enzyme mix     MBI Fermentas 
2.1.5 Reagents  
DNA size markers      MBI Fermentas  
Protein size markers      MBI Fermentas  
Restriction enzymes      MBI Fermentas  
  
2.1.6 Antibodies  
Anti-mouse NFATc1 polyclonal rabbit   ImmunoGlobe  
Anti-mouse NFATc2 polyclonal rabbit   ImmunoGlobe 
Anti-mouse NFATc1 ponoclonal rabbit  Alexis Biochemicals  
Anti-mouse NF-kB p50 polyclonal rabbit   Santa Cruz Biotechnology 
Anti-mouse NF-kB p65 polyclonal rabbit   Santa Cruz Biotechnology  
Anti-mouse NF-κB cRel polyclonal rabbit  Santa Cruz Biotechnology  
Anti-mouse Oct-1 polyclonal rabbit   Abcam  
2.1.7 Oligonucleotides  
The oligonucleotides listed below were synthesized commercially by MWG 
Biotech. The  
lyophilized oligos were dissolved in TE buffer at 100 pmol/µl and stored at – 20o C.  
  
Long-distance PCR  for screening of positive ES cell clones:                                          
sense 35406s   CCTAGCCTGGTGCACCGTACCTGCCCAC 
antisense neo3872as  CCGCTTCCATTGCTCAGCGGTGCTGTCC 
Primers for probe preparation used in Southern blotting:  
Probe 1_forward (5 ́):  5 ́- TGGGGTGAAAAGTTATTTATTG - 3 ́  
Probe 1_reverse (5 ́):   5 ́- TCAGTGAGTCCTAGTGTCGC - 3 ́  
2. Materials and Methods 
 - 13 - 
Probe 2_forward (3 ́):   5 ́- GCTTATTTGCGGACCATT - 3 ́  
Probe 2_reverse (3 ́):   5 ́- CAGCCAACTTTCACCTTTCA - 3 ́  
Probe 3_forward (neo): 5 ́- TCGCACACATTCCACATCCACC - 3 ́  
Probe 3_reverse (neo): 5 ́- CGTGCAATCCATCTTGTTCAA - 3 ́  
Probe 4_forward (5 ́):  5 ́- GGGTGGATAACCAAATGTGCC - 3 ́  
Probe 4_reverse (5 ́):  5 ́- AGCCCTTTCCTGTCTGTCTCA - 3 ́  
 
ChIP : 
CHIP primers for pKC theta promoter: 
Direct:   5’-TTGCTCCACCCTCTACGCAGTATG-3’ 
Reverse:  5’-ACATCAGCTGTCAGAAATGAGAAC-3’  
CHIP primers of mouse NFATc1-promoter 1: 
Forward:  5’-CGTACAGCAAGCAATCCAGTTCG3-’ 
Reverse:  5’-GACTGGAGGGAGCTCCCAG-3’ 
 
EMSA : 
Human PKCθ_NFAT_AP1: 
Antisense: 5’-TTG GAG AGT GAG GCA AAA GTT TTC CAA TAT TTT AT-3’ 
Sense:  5’-ATA AAA TAT TGG AAA ACT TTT GCC TCA CTC TCC AA-3’ 
Human PKCθ_NFATmut_AP1: 
Antisense: 5’-TTG GAG AGT GAG GCA AAA GTT TTG GAA TAT TTT AT-3’ 
Sense:  5’-ATA AAA TAT TCC AAA ACT TTT GCC TCA CTC TCC AA-3’ 
Chicken PKCθ_NFAT binding : 
Antisense: 5’-TAT TCA GGA TGG AAA TAA TCT TAG GCT TTC AAC TGA-3’ 
Sense:  5’-TCA GTT GAA AGC CTA AGA TTA TTT CCA TCC TGA ATA-3’ 
Chicken PKCθ_NFATmutant binding : 
Antisense: 5’-TAT TCA GGA TCC AAA TAA TCT TAG GCT TTC AAC TGA-3’ 
Sense:  5’-TCA GTT GAA AGC CTA AGA TTA TTT GGA TCC TGA ATA-3’ 
 
mNFATc1-IgkB_sense 5'-TGCACAGAGGGGACTTTCCGAGAGGC-3'  
mNFATc1- IgkB_antisense 5'-GCCTCTCGGAAAGTCCCCTCTGTGCA-3'  
mNFATc1-P1kB_ sense 5'-TAGCGGGATGGGAATTTCCTTACTCC-3'  
mNFATc1-P1kB_ antisense 5'-GGAGTAAGGAAATTCCCATCCCGCTA-3'    
mNF-ATc1-P1kB-mut_sense 5'-TAGCGGGATTTGAATTTCCTTACTCC-3'  
 
mNF-ATc-P1kB-mut_anti 5'-GGAGTAAGGAAATTCAAATCCCGCTA-3'  
mPubd-NFATc1-mut_sense  5'-CAAAGACCAAAATTTGTTTCATACAGAAG-3'  
mPu-bd-NfATc1-mut_anti  5'-CTTCTGTATGAAACAAATTTTGGTCTTTG-3'    
mIL2-Pubd-NFATc1_sense 5'-CAAAGAGGAAAATTTGTTTCATACAGAAG-3'  
mIL2-Pubd-NfATc1_anti 5'-CTTCTGTATGAAACAAATTTTCCTCTTTG-3'    
2.1.8 Antibiotics  
Ampicillin      Hoecher  
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G-418      Invitrogen  
Streptomycin     Hoecher  
Ganciclovir      Cytovene, Syntex 
Ciprofloxacin     Phamcy of Clinical center, Wuerzburg 
university 
2.1.9 Solutions and buffers  
Mili-Q grade water was used to prepare all the solutions. The solutions 
were sterilized by  
either autoclaving or filtration.  
2.1.9.1 Gernaral solutions  
APS solution     1 %  
CaCl2                         2 M  
DTT       1M  
EDTA      0.5 M, pH 8.0  
EGTA      0.1 M, pH 8.0  
Ethanol      70 %  
Ethium bromide        10 mg/ml  
Glycine                             1 M  
Hepes                             0.5 M, pH 7.9  
KCl                              1 M  
KH2PO4                            5 mM, pH 7.8  
LiCl                             8 M  
MgCl2                              1 M  
NaAc                             3 M, pH 5.2  
NaCl                             5 M  
NaOH                               10 N  
Phenol: chloroform: isoamylalcohol 25:24:1  
PMSF      0.1 M in 100 % Ethanol               
SDS                             20 %  
SDS                                10 %  
Tris-HCl                              1 M, pH 6.8  
Tris-HCl                              0.5 M, pH 7.6  
Tris-HCl                    0.5 M, pH 6.8  
Tris-HCl                      0.5 M, pH 8.0  
Tris-HCl                       1.5 M, pH 8.8  
Triton X100                         10 %       
2.1.9.2 Buffers   
ChIP buffers  
Cell lysis buffer:   
Hepes      25 mM, pH 7.9            
MgCl2       1.5 mM            
KCl        10 mM            
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NP-40     1 %              
PMSF    1 mM            
  
Sonification buffer : 
Hepes    50 mM         
Nacl     140 mM         
EDTA    1 mM        
Triton X-100    1 %          
Na-deoxycholat       0.1 %           
SDS      0.1 %           
PMSF      1 mM       
  
High salt buffer:  
Hepes    50 mM         
Nacl      500 mM         
EDTA    1mM         
Triton X-100   1 %          
Na-deoxycholat   0.1 %           
SDS     0.1 %           
  
LiCl buffer: 
Tris          20 mM, pH 8.0        
EDTA    1 mM        
LiCl      250 mM        
NP-40    0.5 %          
Na-deoxycholat   0.5 %          
  
Elution buffer:  
Tris     50 mM, pH 8.0      
EDTA          1 mM     
SDS     1 %        
  
EMSA buffers  
Buffer A :  
HEPES    10  mM      
KCl     10  mM  
EDTA          0.1 mM   
EGTA    0.1 mM   
DTT      1.0 mM        
PMSF     0.5 mM      
  
Buffer C :  
 HEPES     1mM   
 NaCl     400 mM  
 EDTA     1 mM      
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 EGTA     1 mM      
 DTT     1 mM        
 PMSF    0.5 mM   
  
5x Binding buffer  
For purified proteins:  
Hepes    100 mM, pH 7.9  
DTT     2 mM  
NP-40    0.5 %  
BSA     0.5 mg/ml  
NaCl     200 mM  
Glycerol    20 %  
  
For nuclear extract preparations:  
Hepes              100 mM, pH 7.9  
DTT              2 mM  
NP-40         0.5 %  
BSA                  0.5 %  
Glycerol    20 %  
  
10 x annealing buffer:  
Tris-HCl    200  mM, pH 7.6    
EDTA    10   mM    
NaCl     500  mM    
  
50x TAE buffer:   
Tris     242 g  
EDTA 0.5 M, pH 8.0  100 ml  
Acetic acid    57.1 ml  
  
5x TBE, 1 litre:   
Tris base    54 g   
Boric acid    27.5 g   
EDTA, 0.5 M, pH 8.0  20 ml    
  
CaCl2 (for preparation of competent bacteria with TopF):   
CaCl2    60 mM  
Pipes    10 mM, pH 7.0   
 
Glycerol    15 %  
  
TE buffer:  
Tris-HCl    10 mM, pH 8.0  
EDTA    1 mM, pH 8.0   
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PBS (phosphate-buffered saline), pH 7.4 : 
Na2HPO4     4.3 mM   
KH2PO4     1.4 mM   
NaCl      137 mM  
KCl      2.7 mM  
  
2 X HBS (HEPES buffered saline), pH 7.05:  
HEPES      50 mM, pH 7.1    
NaCl      280 mM  
Na2HPO4     1.5 mM  
  
TBS (tris-buffered saline), pH 7.4 : 
Tris      25 mM  
NaCl      137 mM  
KCl       2.7 mM  
  
Western blot blocking and hybridization solution :    
TBS, pH 7.4    1x  
Tween-20      1 %  
Nonfat dried milk    1 %   
  
Western blot washing buffer :  
TBS, pH7.4    1x 
Tween-20     0.1 %  
  
2 x SDS gel-loading buffer:  
Tris-HCl     100 mM, pH 6.8  
DTT      200 mM  
SDS      4 %  
Bromophenol blue   0.2 %  
Glycerol     20 %  
  
Western blot transfer buffer:  
Glycine     39 mM  
Tris base     48 mM  
SDS      0.037 %  
Methanol     20 %  
  
Coomassie blue solution (1000 ml): 
Coomassie brilliant blue R-250 2.5 g  
Methanol     450 ml  
Acetic acid     100 ml  
  
SDS-PAGE gel destaining solution:              
Acetic     10 %  
2. Materials and Methods 
 - 18 - 
Methanol     30 %     
  
Gel fixing solution:  
Acetic acid     10 %  
Methanol     10 %  
  
FACS buffer:  
PBS pH 7.4  
BSA      0.2 %  
 
For Nucleic Acid Transfers  
The following solutions are noted in the transfer protocols. All solutions should  
be prepared with sterile, double-distilled deionized water with high-grade reagents.  
Filter stock solutions through a cellulose acetate filter with a glass fiber prefilter (e.g.,  
bottle-top filter).  
  
SSC (1x)        (20x)  
• 0.15 M NaCl                          • 3.0 M NaCl  
• 15 mM sodium citrate pH 7.0    • 0.3 M sodium citrate pH 7.0  
  
TBS (1x  TurboBlotter Alkaline Transfer Buffer): 
• 50 mM Tris       • 3 M NaCl  
• 150 mM NaCl (pH 10x stock to 7.5)  • 8 mM NaOH  
  
BLOCKING AGENTS  
50 x Denhardt's Solutions:  
5g of Ficoll  
5g of Polyvinylpyrrolidone  
5g of BSA  
Adding water to 500 ml  
 
ALKALINE TRANSFER BUFFERS  
To make one liter:  
Denaturing buffer   Transfer buffer:   Neutralizing buffer 5x:  
3 M NaCl, 0.4 M NaOH  3 M NaCl, 8 mM NaOH 1 M phosphate buffer, 
pH 6.8  
175.5 g NaCl    175.5 g NaCl    79.25 g Na2HPO4  
16.0 g NaOH    32 g NaOH   60.25 g NaH2PO4•H2O  
873.0 ml ddH2O    879.0 ml ddH2       Bring to 1 liter with ddH2O  
  
 
For isolation of genomic DNA from ES cells in 96 well plates  
Required Reagents and Materials:  
1. Lysis Buffer for 100 ml:  
10 mM Tris-HCl pH 7.5  0.5 ml of 2 M stock  
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10 mM EDTA    2 ml of 0.5 M stock  
10 mM NaCl     0.2 ml of 5 M stock  
0.5% Sarcosyl* or SDS w/v  0.5 g / 100 ml  
1 mg/ml proteinase K   5ml of 20mg/ml proteinase K (add fresh each 
time,  
                                                        stored in –80° freezer)  
  
2. Precipitation Buffer for 100 ml (fresh):  
150 mM NaCl    3 ml of 5 M stock  
100% EtOH    97 ml 100% ETOH    (This solution remains 
slurry)  
  
3. Wash Buffer for 200 ml:  
70% EtOH     140 ml 100% EtOH  
60 ml ddH2O  
  
4. Resuspension Buffer: for 25 ml:  
10 mM Tris-HCl pH 8.0:  0.125 ml of 2 M stock  
10 mM EDTA:    0.5 ml of 0.5 M stock  
  
5. PBS without Ca2+ and Mg2+  
  
2.1.10 Growth medium  
2.1.10.1 Cell culture medium  
RPMI1640 plus   
FCS      5 %  
L-glutamin      2 mM  
2-mercaptoethanol   50  
2.1.10.2 Bacterial culture medium  
LB broth   
LB agar (1.5 %) 
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2.1.10.3 For ES cells:  
MEF medium: 
 
  
 
  ES medium: 
Components ratio volume(ml) stock 
 non amino-acid 1% 5  
 pyruvate 1% 5  
 β-mercapto 0.10% 0.5  
 FBS 15% 75  
 LIF  0.05 10exp7u/ml 
 DMEM 82.10% 414.5  
  
ES cell media with G418 (500ml): 
Reagents Volume(ml) 
DMEM (with 4500 mg/L glucose, L-GlutaMAXTM, 
without Na Pyruvate) 431.95 
10% FCS 50 
ß-Mercaptoethanol (50 mM) 0.5 
100 x non-essential amino acids 5 
100 x Penicillin/Streptomycin 5 
Nucleoside stock (100x) 5 
107 u/ml LIF (ESGROTM, CHEMICON 
International Inc) 0.05 
G418 (50mg/ml) 2.5 
Total 500 
ES cell media with G418 and Ganciclovir (500ml): 
Reagents                                                                                                          
  
Volume(ml) 
DMEM (with 4500 mg/L glucose, L-GlutaMAXTM, without 
Na Pyruvate)                       431.45 
10% FCS                                                                                                           50
ß-Mercaptoethanol (50 mM)                                                                                0.5
100 x non-essential amino acids                                                                           5
100 x Penicillin/Streptomycin                                                                                5 
Nucleoside stock (100x)                                                                                        5
107 u/ml LIF (ESGROTM, CHEMICON International Inc)                                            0.05 
2mM ganciclovir (1000 x)   0.5 
G418 (50mg/ml)                                                                                               2.5 
Total                                                                                                                  500 
components ratio volume(ml) volume(ml) 
 non amino-acid 1% 5 5.688 
 pyrutate 1% 5 5.688 
 B-mercapto 0.10% 0.5 0.5688 
 FBS 10% 50 56.88 
 DMEM 87.90% 439.5 500 
 TOTAL  500 568.83 
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ES media Cryopreservation Medium: 
1. 60% DMEM 
2. 20 % FBS 
3. 20 % DMSO 
 
2.1.11 Bacterial strains  
E.coli strains TopF, DH5 
2.1.12 Mammalian cell lines  
EL-4       DSMZ (murine thymoma cell line ) 
Jurkat      DSMZ (human T cell leukemia line) 
DT40 chicken B cells: WT, NFATc1-/-/-, NFATc1-/-/αΑ , NFATc1-/-/αC  Kondo et al. 
Embryonic stem (ES) cells:    TC-1 The laboratory of R. Flavell, 
Yale university,New  Haven, USA  
2.1.13 Mice  
BL6 wild-type     Charles River  
Balb/c wild-type     Charles River 
C57BL/6      Charles River 
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2.2 Methods 
2.2.1 Bacterial manipulation  
2.2.1.1 Storage of bacteria  
1 ml of overnight bacterial culture was centrifuged at 5000 rpm for 3 minutes 
at RT. The collected bacteria were resuspended in 200µl (containing 20% 
glycerol) and stored at – 70 oC.   
  
2.2.1.2 E.coli competent cell preparation (CaCl2 method)   
A single colony of TopF was inoculated into 50 ml of antibiotics-free LB 
broth. The bacteria grew at 37 oC with shaking overnight. Next day, 30 ml of 
the culture were diluted into 350 ml of antibiotics-free LB broth and shake-
cultured at 37 oC. The OD595 of the culture was monitored every 20-30 
minutes until OD595 reached 0.4 - 0.6. The culture was divided into six ice-
cold 50 ml Falcon tubes and cooled on ice for 10 minutes. The bacteria 
were washed once in 20 ml of ice-cold CaCl2 solution. The washed bacteria 
were then incubated on ice for 30 minutes once in 50 ml of ice-cold CaCl2 
solution and once in 4 ml of ice-cold CaCl2  solution. 0.2 ml of competent 
cells in 1.5 ml Eppendorf tubes was stored at –70 oC.  
  
2.2.1.3 E.coli competent cell transformation   
1 µl of plasmid or no more than 10 µl of a ligation reaction were added into 
thawed competent cells and incubated on ice for 30 minutes. The 
competent cells were then heat- shocked at 42o C for 60 seconds and 
cooled on ice for 2 minutes. 800 µl of antibiotics- free LB broth was added, 
and the bacteria were shaken-cultured at 37o C for one hour. 100 µl of 
transformed bacteria were plated onto LB agar plates containing 50 
ampicillin and the plates were incubated at 37 oC for 16 hours.   
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2.2.2 DNA methods  
2.2.2.1 Plasmid DNA purification (NucleoBond® Macherey-Nagel)  
1 colony of transformed bacteria was inoculated into 400 ml of ampicillin-
containing LB broth and shaken-cultured at 37oC overnight. Next day, the 
bacteria were collected and resuspended in 15 ml of buffer S1 and lysed by 
15 ml of buffer S2 at RT for 5 minutes. The lysate was then neutralized by 
15 ml of buffer S3. The clarified supernatant was loaded onto a 
NucleoBond® Maxi column equilibrated with equilibration buffer and the 
solution was passed through the column by gravity. The column was 
washed once with 30 ml of wash buffer and the column-bound DNA was 
eluted with 15 ml of elution buffer. The eluate was precipitated by 12 ml of 
2-propanol. The pellet was washed once with 70% ethanol and dissolved in 
200 µl of TE buffer.  For mini-preparations, bacteria collected from a 1.5 ml 
culture were resuspended in 150 µl of buffer S1, lysed in 150 µl of buffer 
S2, and neutralized in 150 µl buffer S3. The clarified lysate was precipitated 
in 77% 2-propanol. The precipitated pellet was washed once in 70% ethanol 
and air-dried. The dried pellet was dissolved in 50 µl TE. 20 µl of miniprep 
DNA were used for digestion.    
    
2.2.2.2 Determination of DNA/RNA concentration   
0.1 ml of DNA/RNA solutions was transferred into a quartz cuvette and the 
OD260 of the sample was measured. The concentration of DNA/RNA 
solutions was calculated automatically. For reference, 1 unit of OD260 = 50 
µg /ml of double strand DNA (dsDNA) or 40 ug/ml of RNA.  
  
2. Materials and Methods 
 - 24 - 
2.2.2.3 Polymerase chain reaction (PCR) of DNA fragments 
(Fermentas PCR kit)  
2x Master-mix（25ul/tube）Fermentas: 
1. 0.05 u/µl Taq DNA Polymerase (recombinant) 
2. reaction buffer 
3. 4 mM MgCl2 
4. 0.4 mM of each dNTP (dATP, dCTP, dGTP, dTTP). 
Primer mix:10ul/tube 
Primer chicken PKCθ or mouse IL-2 sense: 0.2uM—1ulx23=23ul  stock 10uM 
Primer chicken PKCθ or mouse IL-2 sense anti: 0.2uM— 1ulx23=23ul stock 10uM 
H2O: 7ulx23=161µl  
Template: 15ul/tube 
Template DNA :2.5ul---input control 1ul for EL4, while 7.5ul---input control 
1ul for DT40 
Fresh Deionized Water: to 15µl H2O 
PCR programme: 
Initial denaturation :95℃*3min 
Circulation:[denaturation 95℃*40sec—primer annealing 58℃*40s—
extending 72℃*70s]*40times,  
Final extending :72℃*5min, Store at 4℃ forever 
 
Long distance PCR for screening and temperature cycling: 
Step     Temp(°C) Time(min) cycling 
Initial denaturation step  94  5:00  1 X 
Denaturation step   94  0:20 
Annealing and extending step 66  3:00 +0:05 30 X 
Final extending step   68  10:00  1 X 
End     4  forever 1X 
 
2.2.2.4 Restriction enzyme digestions of DNA  
40 µl digestion reaction containing 0.5-1 µg DNA or 20 µl of miniprep DNA, 
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1x digestion buffer, and 4 µl restriction enzyme were incubated at 37 oC for 
1 hours to overnight. The reaction was resolved on an agarose gel.   
2.2.2.5 Agarose gel electrophoresis of DNA  
A proper concentration of agarose in 1x TAE buffer was melted and casted 
in the gel casting mould. 2 µl samples containing 1x loading dye were 
loaded onto the gel that was then run in 1x TAE buffer at 150 volts for a 
proper duration. The resolved DNA was visualized under UV- light using a 
gel camera and recorded using a gel documentation system.   
  
2.2.2.6 DNA fragment extraction from agarose gels (QIAEX II kit)  
The cut gel slice containing a DNA fragment was weighed and transferred 
to a 1.5 ml Eppendorf tube. 3 volumes of buffer QX1 and 1 tenth volume of 
QIAEXII beads were added to the gel and incubated at 50 oC for 10 
minutes. The beads were collected by centrifugation and washed once with 
buffer QX1 and once with buffer PE. For DNA elution, the beads were air-
dried, resuspended in 50 µl of EB buffer and incubated at 50oC for 5 
minutes. The supernatant containing the DNA fragment was then collected, 
and the beads were discarded. The supernatant was transferred to a fresh 
Eppendorf tube and stored at -20 oC.    
  
2.2.2.7 Ligation of DNA fragments  
20 µl ligation reaction containing 1x ligation buffer, 100 ng vector, a proper 
amount of inert DNA (which makes the insert/vector ratio at 5-10 : 1), and 2 
µl T4 DNA ligase were incubated at 16 oC for 4 hours to overnight. The 
ligation product was transformed into competent bacterial cells.  
2.2.2.8 Southern blotting  
Separate DNA fragments on a 0.8% agarose gel in TAE buffer overnight. 
Immerse gels in 0.25 N HCl (500 ml for a 200 ml gel) for 15 min at room 
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temperature, agitate gently. Denature gel by soaking in denaturation 
solution (3 M NaCl, 0.4 M NaOH) two times for 30 min each (Shake the dish 
containing the gel slowly), then soak in transfer buffer (8 mM NaOH, 3 M 
NaCl) for 15 min. Float nitrocellulose filter membrane in distilled water for 15 
min. (If dry spots remain, heat membrane in water briefly until boiling.) Soak 
membrane in 3 M NaCl, 8 mM NaOH transfer buffer. The membrane should 
be thoroughly wetted with transfer buffer before using. Set up downward 
capillary transfers, continue the transfer for 4 h by alkaline buffer transfer. 
Then, the membrane was ready for hybridization. Prepare probe by 
random-primed labeling.   
 
High Temperature Hybridization Solution (68°C)    
Pre- or hybridization      Solution Stock  Volume(10ml)  
2 x Denhardt’s solution     50 x    0.4ml  
6 x SSC (or SSPE)      20 x    3.0ml  
0.5% SDS       10%    0.5ml  
1mM CTAB       0.1M    100µl  
100 µg/ml denatured DNA (freshly denatured)*  10mg/ml   100µl  
 dH2O to 10ml                                       5.9ml  
*Salmon testis DNA (Sigma D-9156), 10.4 mg/ml, boiled 5 min before use, and added  
freshly each time.   
  
Place the membrane in hybridization bottle with 10 ml (minimal 100 µl/cm2 
filter) of prehybridization buffer (use nylon mesh as a spacer). Incubate for 
1–2 hrs at 68° C. Denature probe at 95°C for 5 min, then add probe in 
hybridization bottle, hybridize at 68° C overnight. Wash membrane three 
times for at least 15 min, each with at least 125 ml/100 cm2 of 7x 
SSPE/0.1–0.5% SDS at room temperature. Then wash membrane twice for 
at least 15 min each in 1x SSPE/0.5-1.0% SDS at 37° C. Wash finally for 15 
min~1 h in 0.1x SSPE/1% SDS at 65° C. Measure the counts coming off the 
membrane with a Geiger monitor. Stop washing when the counts dropped 
from 200 to 700 cpm. If the counts were above this, continue washing as 
outlined below. Be sure to check the counts between each change of wash 
buffer. After washing, blot filters with filter paper (Whatman 3MM) to remove 
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most of the excess moisture. Wrap moist blots in plastic wrap prior to 
autoradiography. Expose filters to Kodak MS film at –70° C with an 
intensifying screen for 1 day.   
2.2.3 Protein methods  
2.2.3.1 Expression and purification of GST fusion proteins (Sigma 
GST fusion purification kit)   
One colony of bacteria harboring pGEM-GST-RSD was inoculated to 50 ml 
of LB broth containing 50 µg/ml ampicillin. The bacteria were shaken-
cultured at 37o C overnight. Next day, the culture was transferred to 1500 ml 
of ampicillin-containing LB broth which was then shaken-cultured at 37 oC 
until OD595 incubating the culture at 27 oC with shaking in the presence of 
0.1 mM of IPTG for 2 hours. The collected bacteria were resuspended in 20 
ml of cold PBS plus 0.2 ml of Triton X-100. The bacteria suspension was 
sonicated on ice at full power until the color of the bacteria suspension was 
changed from yellow to white. The clarified supernatant was mixed with 
1.25 ml of 80% Glutathione Sepharose® 4 B beads and incubated at 4 oC 
for 2 hours. The beads were washed 4 times with PBS at RT, 5 minutes 
each, followed by twice washing with 50 mM Tris-HCl, pH 8.0. The beads 
were eluted with 10 mM glutathione in 50 mM tris-HCl, pH 8.0, at 30 oC, for 
10 minutes. The eluate was stored at -20 oC.   
2.2.3.2 Nuclear extract preparation  
Up to 108 cells were lysed on ice for 30 minutes in 10 ml of buffer A plus 
0.5% NP-40 and then vortexed for 10 seconds. The nuclei were collected 
and resuspended in buffer C at 107 cells/50 µl of buffer C. The nucleus 
solution was vortexed at 4 oC for 30 minutes and clarified. The clarified 
supernatant was transferred to a fresh Eppendorf tube and stored at – 70 
oC.  
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2.2.3.3 Determination of protein concentration (Bradford method)  
Bio-Rad Dye Reagent Concentrate was five times diluted in ddH2O before 
use. A BSA standard was prepared at five concentrations. 20 µl of protein 
sample was mixed with 980 µl of diluted Dye reagent in a 1 ml plastic 
cuvette and incubated at RT for 5 minutes. The OD595 of the samples were 
measured in a spectrophotometer. The protein concentrations were 
calculated according to the BSA protein standard curve.  
  
2.2.3.4 SDS-PAGE electrophoresis of proteins   
A 10% separating gel and a 5% stacking gel were casted sequentially in the 
gel casting mould according to the recipes listed below. 30 µl of protein 
sample containing 30 µg protein and 1x SDS-PAGE loading dye was 
heated at 95 oC for 5 minutes. The samples and the protein size markers 
were loaded onto the gel, and the electrophoresis was carried out in the 1x 
SDS-PAGE running buffer at 100V and 35mA until the dye was migrated to 
the bottom of the gel.  
                       
SDS-PAGE gel preparation 
      10% separating  5% stacking  
Reagent     volume (ml)   volume (ml)                       
ddH2O     4.0    3.56  
30 % gel stock    3.3    0.67  
1.5 M Tris, pH 8.8   2.5                    
1.0 M Tris, pH 6.8       0.63  
10% SDS     0.1    0.05  
10% APS     0.1    0.05  
TEMED     0.01    0.005  
Total volume    10    5        
                           
  
2.2.3.5 Western blotting and immunodetection  
The resolved proteins in the SDS-PAGE gel were transferred onto a 
nitrocellulose membrane at 100V or 0.35A for one hr. The membrane was 
then washed once with PBS and then blocked for 30 minutes at RT in 
2. Materials and Methods 
 - 29 - 
blocking solution. The membrane was then probed with the primary 
antibody diluted in blocking solution (1: 10000 for anti-NFATc1 antibody) at 
4 oC overnight with gently shaking. Next day, the membrane was washed 
three times with washing solution followed by incubating with secondary 
antibody diluted in blocking solution (1:2000 for anti-mouse IgG-HRP 
conjugate) at 4 oC for 4 hrs. The membrane was washed five times, 5 
minutes each, at RT with washing solution. To reveal the specific protein 
band, the membrane was rinsed in ECL developing solution and exposed to 
an X-ray film for a satisfied time. The exposed film was then developed and 
fixed.   
  
2.2.3.6 Electrophoretic mobility shift assay (EMSA)   
2.2.3.6.1 Probe preparation   
For oligo annealing, two single strand oligonucleotides of equal 
concentration were mixed in 20 µl of 1x annealing solution, heated at 95 oC, 
and cooled naturally to RT in the heating blocks. For labeling, 10 µl labeling 
reaction containing 1x PNK buffer, 5pmol (1 µl) of double strand oligo, 1 µl 
of T4 kinase, 1 µl  10x PNK buffer A and 3-5 µl of 32P γATP 37 oC for one 
hours.  
2.2.3.6.2 Purification of labeled probes  
Purification on a 10% native DNA gel.  10 µl of labeling reaction were 
loaded onto a 10% native DNA gel which was then run in 0.5x TBE at 240V 
until dye migrated to one fourth of the gel. The gel was exposed to an X-ray 
film for 2 minutes. The gel area containing the probe as revealed by the X-
ray film was cut and eluted in 200 µl of TE, pH 8.0. The eluted probe was 
diluted to 6000 cpm/4µl.  
Purification on a Sephadex G-50 column. Column was prepared by loading 
200 µl of 50% Sephadex G-50 in TE, pH 8.0, into a 200 µl filter tip which 
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was vertically mounted into a 1.5 ml Eppendorf tube through a cross-cut 
made on the lid of the tube. The column was centrifuged at 3000 rpm for 3 
minutes and flow-through was discarded. 20 µl of labeling reaction was 
loaded onto the column and centrifuged at 3000 rpm for 3 minutes. The 
flow-through was diluted to 20.000 cpm/4 µl.     
2.2.3.6.3 Binding reaction  
A 10 µl binding reaction contains 3.3x binding buffer, 0.7 µl poly dI·dC, 1-4 
µl protein, and 1 µl probe. The reaction was incubated at RT for 15 minutes. 
In competition assays, 0.5 and 5 pmol of double strand oligos (5 pmol/1 µl) 
were included in the reaction. In super-shift assays, 1µl of antibody was 
included in the reaction. The total volume in competition and super-shift 
assays was adjusted to 10 µl. The reaction was resolved on a 5% native 
PAGE.  
2.2.3.6.4 Native gel electrophoresis of protein-DNA complexes  
A 5% native PAGE gel was casted according to the recipe listed below in 
the gel casting mould. 10 µl of binding reaction was loaded onto the gel 
prerun for 2 hrs at 240V and the electrophoresis was carried out in 0.25X 
TBE at 10 mA in the cold room until the dye migrated close to the bottom of 
the gel. The gel was fixed, dried, and exposed to an X-ray film.    
                   
             Preparation of 60 ml native gel solution            
Gel concentration   5%   10% 
Reagent                        volume (ml) 
ddH2O    48   36.7 
30% PAGE    10   20 
10x TBE    1.5(x 0.25)  3(x 0.5) 
10% APS    0.3   0.1 
TEMED    0.1   0.05 
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2.2.3.7 Chromatin immuno-precipitation (ChIP) assay  
2.2.3.7.1 Chromatin preparation  
2x108 cells were fixed on ice or 5 minutes in 1% formaldehyde in 37 ml of 
RPMI1640. The cells were then lysed on ice for 30 minutes in 20 ml of ChIP 
lysis buffer and vortexed for 30 seconds. The chromatin was collected, 
resuspended in 2 ml of sonification buffer and sonicated on ice for 9 cycles, 
each for 30 seconds at max power, 0.5 duty cycle followed by cooling on ice 
for 30 seconds. The sheared chromatin was then clarified. The clear 
chromatin solution was transferred to a 1.5 ml fresh Eppendorf tube. The 
OD260 of the chromatin solutions was taken and the chromatin solutions 
were adjusted to equal OD260 units with sonification buffer and stored at -
70 oC.  
2.2.3.7.2 Immuno-precipitation of the sheared chromatin  
One ml of chromatin was pre-cleared with 50 µl of salmon sperm 
DNA/protein A agarose slurry. Chromatin equal to 107 lymphocytes in 300 µl 
was incubated with 3 µl of anti-NFATc1 antibody, or 3 µl of anti-NF-kB p50 
or p65 antibodies at 4 oC overnight with rotation. Next morning, 30 µl of 
salmon sperm DNA/protein A agarose slurry was added to each reaction 
and incubated at 4 oC for 2 hours with rotation. The recovered beads were 
washed sequentially with sonification buffer, high salt solution, LiCl solution, 
and TE. Twice for each solution, 5 minutes each. The beads were 
resuspended in 300 µl of elution solution plus 10 µl of 5M NaCl. 30 µl of 
input chromatin was also diluted to 300 µl with elution solution and 10 µl of 
5M NaCl were added. The beads and the input chromatin were incubated at 
65 oC for overnight and extracted once with PCI(phenol:chloroform:isoamyl 
alcohol). The water phase was precipitated by 70 % ethanol plus 0.1 M 
(NH4)3Ac, pH 5.2. The precipitated DNA was washed once with 70% 
ethanol, and dissolved in 50 µl of TE and stored at – 20 oC.   
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2.2.4 Cell culture methods  
2.2.4.1 Storage of cell lines  
Chicken DT40 B cells, Jurkat T cells and EL-4 T cells were grown in 
complete RPMI 1640 medium supplemented with 5% fetal calf serum (FCS) 
and penicillin plus streptomycin. For storage, 5 x 106 cells in 1 ml of frozen 
solution (90% FCS and 10% DMSO) were frozen at -70 oC.   
  
2.2.4.2 Maintenance of cell lines  
The cell culture work was done under sterile conditions in laminar hoods. All 
cells were cultured at 37°C (except DT40 cells: 39.5°C ) in a humidified 
tissue culture incubator. To start a cell culture, the frozen cells were thawed 
in a 37 oC water bath and transferred to a cell culture flask containing 20 ml 
of medium. The cells were splitted twice a week at 1: 5-10 dilutions to 
maintain the cells at a density of 1- 4 x 105 cells /ml.   
  
2.2.4.3 Cell stimulation  
In stimulation experiments, 5x 107 of cells DT40, Jurkat and EL-4 cells were 
pre-cultured in 50 ml of complete RPMI1640 at 39.5 oC or 37 oC for 2 hours. 
To stimulate the cells, ionomycin (0.5 µM) or TPA (20 ng/ml) + ionomycin 
(0.5 µM) were mixed with the cells, and the cells were incubated at 39.5 oC 
or 37 oC for 4 hours, or H2O2 ( 0.5,1,2,5,10 µM) was mixed with cells for 4, 
or 8, or 12, or 24 hours. In inhibition experiments, inhibition reagents were 
added to the desired concentration and the cells were incubated at 37 oC for 
one hour. In ChIP experiments, up to 2x108 of thymocytes in 50 ml of 
complete RPMI1640 were incubated with TPA+ionomycin as described 
above.   
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2.2.5 FACS staining and apoptosis analysis 
Staining  
1. Wash cells twice with cold PBS and then resuspend cells in 1×binding 
buffer at a concentration of 1 x 106cells/ml.  
2. Transfer 100 µl of the solution (1 ×105cells) to a 5 ml culture tube.  
3. Add 5 µl of Annexin V-APC (BDPharmingenTM ) and 5 µl of propidium 
iodide (PI, just before analysis).  
4. Gently vortex the cells and incubate for 15 min at RT in the dark.  
5. Add 400 µl of 1×binding buffer to each tube. Analyze by flow cytometry 
within one hour.  Samples were analyzed on a FACScan flow cytometer 
(Becton Dickinson).  
10×Binding Buffer: 0.1 M Hepes (pH 7.4) 1.4 M NaCl, 25 mM CaCl2.  Store 
at 4 0C.  
The following controls are used to set up compensation and quadrants:  
APC emission wavelength is 660 nm and excitation is 650 nm. APC is 
optimized for FL-4 fluorescence on the FACS Calibur.  
1. Unstained cells.  
2. Cells stained with Annexin V-APC alone (no PI).  
3. Cells stained with PI alone (no Annexin V-APC). 
 
2.2.6 ES cell culture and manipulation  
2.2.6.1 Stem cell culture  
Two stem cell lines (E14 and TC-1) were adopted in these experiments, 
both are derived from the 129X1/SvJ mouse strain. These ES cell lines 
have been proven to generate germ line chimeras with high efficiency. To 
maintain ES cells integrity, ES cells were carefully expanded and 
subsequently frozen in liquid nitrogen before screening. All ES cells were 
grown on MEF feeder layers plus LIF cytokine in high quality medium. This 
medium prolonged the embryonic phenotype of the cell line. ES cells grew 
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rapidly, dividing every 18 to 24 h. The cells were kept at relatively high drug 
concentration: densities to ensure that a high rate of cell division was 
maintained as this seems to minimize the level of spontaneous 
differentiation. The cultures were re-fed daily, and subcultured every 2 d. 
When passaged, it was important to trypsinize the cells well to ensure that a 
single cell suspension was generated.  
  
2.2.6.2 Preparation of MEFs  
Fresh MEFs were isolated from mouse embryos. MEFs were cultured until 
passage 3, then frozen in liquid nitrogen as stock. Since MEFs have a 
limited life span in culture after 3 passages, they can be used to support ES 
growth. 
  
2.2.6.3 Preparation of targeting vector DNA , Cre recombinase 
encoding DNA and electroporation 
A large scale preparation of gene targeting vector DNA was prepared and 
purified by the Maxprep kit (QIAGEN). 100 µg of targeting construct DNA 
was digested with an enzyme to linearize. 0.5 µl of digested DNA were 
fractionated on an agarose gel to control that the vector DNA was 
completely digested. The DNA was extracted 2X with phenol/chloroform, 
afterwards 0.15 volumes of 2M NaOAc and 2 volumes EtOH  were added 
for precipitation. The DNA was pelleted, and then washed with 70% EtOH. 
The DNA was resuspended in 100 µl sterile H20 or TE in a laminar flow 
hood. Check 0.5 µl DNA on an agarose gel, and determine DNA 
concentration.   
 
Preparation of ES cells for transformation and electroporation:  Approximately 6 
x 107 ES cells (~3 confluent 10 cm plates) were needed for one electroporation. 
Split one plate of subconfluent ES cells into four dishes such that the next day 
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the cells are ready to be split again. Fed the cells in the morning, as the cells 
were plated more confluent than usual. The cells were ready for electroporation 
after a few hours. Trypsinize the cells: remove the medium and rinse 2 times 
briefly with 10 ml of calcium-free PBS (37°C), add 3 ml of fresh trypsin-EDTA 
and incubate for 5 min at 37°C. Digested cells were checked under the 
microscope to see if the colonies looked like grapes (not single cell). Then the 
cells were pipetted gently in trypsin-EDTA to break up the clumps, after that add 
7 ml medium and pipette gently up and down again. The cells were pelleted for 
5 min at 270g.  Aspirate the supernatant and resuspend the cells in 50ml of 
PBS. Count cells in hemocytometer. The cells were centrifuged and 
resuspended to a final concentration of 2.0~2.5 x 107 cells/1ml PBS. Transfer 
0.8 ml of cell suspension into a 4 mm electroporation cuvette (gap width 0.4 cm) 
with 25~40 µg DNA (1 µg/µl of linearized and purified DNA) as below: Bio-Rad 
electroporator (Gene Pulser II System, Bio-Rad, Inc., CA) -- 250V, 500µF. 
Disconnect the resistance and use the capacity extender to achieve these 
settings. Monitor time constants, which was ~7 seconds.  Let cuvettes sit on ice 
for 20 min and plate onto three 10-cm feeder dishes in regular ES media 
(without G418).   
  
2.2.6.4 Drug selection and cell culture   
The day after electroporation there should be some floating dead cells but 
most cells should sit down on the feeder cells. Start selection 24 h after the 
electroporation with ES medium containing selection drug (250 µg /ml 
G418). After about 6-8 d of selection, individual drug-resistant colonies 
should have appeared and be large enough to pick and subcloned for 
screening.   
   
2.2.6.5 Picking of ES cells and 96-well plate culture  
Wash plate with PBS. Pick the ES colonies when they were easily seen 
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microscopically but have not yet begun to show any signs of differentiation. 
This was usually after ~7-9 d under selection, but some variability was not 
unusual. Pick colonies into a 96 well plate (U shaped wells) with 35 µl of 
trypsin / well. Pick 24 colonies and incubate at 37 oC for 10 min. Used a 
multichannel pipette to break up colonies. Transfer directly into a 96-well 
plate with feeders and 150 µl of ES medium (without selection drug). Fed 
every day with ES medium containing selection drug (250 µg /ml G418). 
Repeat this step on second and third picking days, use the original plates of 
electroporated cells. If the colonies have not grown to ~80% confluence in 
two to three days, trypsinize the cells using the following procedure: 
Aspirate the medium and wash the cells with PBS 2 times. Culture for 
another 3 -5 d.  
 
2.2.6.6 Freezing in 96-well plates  
Working one row at a time using a multichannel pipette. Change the 
medium 2-3 h prior freezing. After 2 days, cells were ready (~80% 
confluence) to be frozen. Wash with PBS, add 35 µl of trypsin, incubate at 
37 oC for 10 min, and add 65 µl of ES medium. Use a multichannel pipette 
to disperse cells. Transfer 65 µl into replica plate (U shaped wells) 
containing 65 µl of cold 2 x ES freezing medium. Wrap with parafilm, place 
in a styrofoam box with dry ice for 20 min, and transfer to -80 oC. After 
removing cells for freezing, add 150 µl of ES medium to left 35 µl cells. 
Grow cells without feeder for 3 - 5 d till the medium became yellow. Split 
into 2 - 4 x 96 well plates for southern blotting and PCR assays.  
  
2.2.6.7 96-well plate DNA extraction  
When cells were confluent, aspirate the medium from each well on the plate 
and wash twice with PBS. Add 50 µl of lysis buffer to each well. Dampen 
some paper towels and place in the bottom of a tupperware container. 
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Place the plates on paper towels and seal the lid of the tupperware 
container. Incubate the plates (with lids on) in this sealed humid container in 
a 56°C incubator overnight.  Add 120 µl of fresh precipitation buffer to each 
well; leave at RT for 4 h to allow the DNA to precipitate, avoiding vibration. 
DNA precipitates were visible against a black background or web-like DNA 
fibers were seen under a low power microscope. Remove lid, take five 
layers of paper towel and pre-wet one side by 70% EtOH, then put the 
wetted-side on plate over open wells. Invert plate together with paper towels 
slowly and keep it on bench for 30 seconds. Lift the plate and blot away 
liquid. The precipitated DNA remained attached to the bottom of wells. 
Wash the precipitated DNA by carefully adding 200 µl of wash buffer 3 
times, keep at room temperature for 10 min for each washing. Each time 
remove alcohol by inversion of plate on paper towels. At this point, DNA 
could be stored in 70% ethanol in a parafilm sealed plate at –20 °C (for four 
to five weeks) until proceeded with diagnostic restriction enzyme digestion 
and PCR assays (or southern blotting). Add 60 dH2O, leave at RT 
overnight. Mix up a sample for a final volume of 40 µl . Check on a 0.8 % 
agarose mini-gel, and if not completely digested, add 10u/per well restriction 
enzyme mix again. Add 4-5 µl of loading buffer to each well, electrophorese 
the digested DNA on an agarose gel at 20 V, overnight. For PCR, use 1~2 
µl of DNA sample. To run a nested-PCR, external PCR: 25~30 cycles were 
run and internal PCR: 15~25 cycles. The expected yield of DNA from each 
plate well was about 10 µg.  
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3. Results 
3.1 Creation of Murine Embryonic Stem Cells Containing a 
Targeted NFATc1 Allele for its Conditional Inactivation in Mice 
3.1.1 The DNA construct for targeting the NFATc1 P1 promoter   
To delete conditionally the promoter P1 of Nfatc1 gene, a targeting vector was 
constructed by Dr. Jiming Liu using the pGL3-basic vector. It was sequenced 
to ensure its fidelity (which is shown in Figure 3-1). The DNA of targeting 
vector was amplified upon transformation, and the recombinant DNA of 
targeting vector was proven to be correct by digestion with Acc65Ι (Figure 3-1-
B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1 Targeting vector for the conditional deletion of the Nfatc1 promoter 
P1 . (A) Scheme of the targeting vector. The pGL3-basic vector was used for 
3. Results 
 - 39 - 
constructing the targeting vector. Serial clonings were done to incorporate the 
following DNA fragments: HSV-TK (herpes simplex virus thymidine kinase) gene for 
negative selection; the left DNA “arm” for site-specific recombination, containing a 
loxp sequence after subcloning, as well as exon 1 and promoter 1 DNA; a PGK-
neomycin resistance gene (for positive selection) flanked by Cre recombinase 
recognition (loxP) sequences; and the right “arm” for site specific recombination 
containing the enhancer and exon 2, and another loxp sequence. (B) Digestion with 
the Acc65I enzyme showing the predicted fragments 
(5873+3527+2721+2296+996=15409) which is in line with the expected outcome. 
Electrophoresis on a 1% agarose gel at 80 V for 100 min:  Positive colonies of E. coli 
carrying the targeting vector are shown in lanes 3,4,5,6 and 8. 
 
3.1.2 Electroporation of targeting vector DNA and double selection of 
recombinant ES cells 
To mutate the endogenous Nfatc1 gene in ES cell, the purified DNA of 
targeting vector was electroporated into TC-1 ES cells (a gift from the 
laboratory of R. Flavell, Yale University, New Haven, USA). During double 
selection with ganciclovir and G418, the quality of feeder layer cells is of 
crucial importance. On radiated feeder layers, the ES cells grew well, and they 
maintained an undifferentiated state (Figure 3-2-B,C,G), while with 
overcrowded feeder layers or without feeder layer, they grew slowly (Figure 3-
2-A,D) or differentiated into many branches (Figure 3-2-E). Interestingly, 
contrary to previous observations (Cohen et al., 2006), in our hands the use of 
antibiotics such as ampicillin, in addition to selection drugs, facilitated the 
differentiation of ES cells (Figure 3-2-F,G). Furthermore, it is compulsory to 
avoid contamination with mycoplasms which can be found in many culture 
media and, therefore, established cell lines. Such a contamination is 
deleterious for maintaining pluripotency which is necessary for the faithful germ 
line transmission of ES cells upon injection into murine blastocysts (Cobo et 
al., 2007). 
 
 
 
 
3. Results 
 - 40 - 
 
 
Figure 3-2 Morphology of murine TC-1 ES cells under different culture 
conditions, as it can be seen by light microscopy.  
(A) ES cell growth on feeder cells which were not radiated. (B and C) Growth on 
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feeder cells which were radiated, magnification:10x and 40x. (D) ES cells without 
MEF feeder cells.  (E) Differentiated ES cells growing without feeder layer and with 
ciprofloxacin. (F) Slightly differentiated ES cells growing on a feeder layer and 
ciprofloxacin. (G) “Normal” ES cells with feeder layer but without ciprofloxacin. 
3.1.3 Preliminary screening of ES cells for site-specific recombination by 
long distance PCR  
To screen the neo-resistant T1-C ES cells for site-specific integration of the 
targeting vector, among the 600 colonies which we have picked according to 
standard procedures (Figure 3-2-C), long distance PCR assays were 
performed using as template the genomic DNA from the above picked clones 
(Loukianov et al., 1997). 10 positive clones were obtained (Figure 3-3).  
 
Figure 3-3 Positive ES cell colonies screened by long distance PCR 
after double selection. The predicted positive PCR fragment has to be 4 
kb in length. 4 positive clones are shown here corresponding to the 
colonies no. 15, 116, 322 and 446. 
3.1.4 Confirmation of positive clones by Southern blot assays 
To ensure the intactness of targeted Nfatc1 locus containing all functionally 
important components, such as the loxP sequences, before injecting positive 
ES cells into blastocysts, Southern blot assays were done using DNA from 
positive ES cell clones. The probe for hybridization was synthesized using as 
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template DNA from a BAC (bacterial artificial chromosome) bearing the murine 
Nfatc1 gene. The NFATc1 
 
C 
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Figure 3-4 Targeting vector for the deletion of the murine Nfatc1 
promoter 1 and the structure of the targeted locus (obtained from Jiming 
Liu).  
(A) Several cloning steps were done (by Jiming Liu) to incorporate the 
following components into the pGL3-Basic vector for constructing the 
targeting vector: HSV-TK (herpes simplex virus thymidine kinase gene), the 
negative selection gene, left arm for site-specific recombination with an 
introduced loxp sequence, exon1 and promoter 1, PGKneo (positive selection 
gene)-the neomycin resistance gene flanked by Cre recombinase recognition 
(loxP) sequences, then the right arm for recombination with enhancer and 
exon 2, and another loxp sequence. (B) The targeted Nfatc1 locus in the 
mouse genome after successful recombination. (C) The wild type locus of 
themurine Nfatc1 gene indicating where the probes are located and the length 
of DNA fragments. 
 
5’ (left) probe spanning 359 bp is located upstream the first loxp site, while the 
3’ (right) one spanning 427 bp in the right arm and downstream the third loxp 
site (Figure 3-4-B). Their hybridized genomic fragments obtained by EcoRI and 
EcoRV digestion are displayed (Table 3-1). Finally, 6 positive clones were 
identified:  the clones No.8, 10, 15, 322, 446 and 560 (Figure 3-5-A and results 
not shown) 
 
Table 2-1 Probes for Southern blot hybridization and their 
corresponding segments of genomic DNA in both wild type (WT) and 
mutated (promoter 1 – P1) ES cells upon cutting by EcoRΙ  and EcoRV.  
 
3.1.5 Cre-recombinase expression in ES cells carrying a mutated Nfatc1 
gene 
To test the efficiency of the Cre system to cut the targeted locus, a vector 
expressing Cre recombinase was electroporated into the mutated ES cell clone 
No.15. The Cre recombinase was expressed and the PGKneo gene was 
removed. The ES cells were found to die in G418 media without PGKneo gene 
    In order to delineate the function of the different 
isoforms of NFATc1 in the apoptosis , the above system 
is used to knockout the chicken endogenous NFATc1 
gene and to incorporate constructs expressing  human 
NFATc1 isoforms:NFATc1/ αA and NFATc1/ αC 
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whereas ES cells with unremoved PGKneo survived, which was proven by 
Southern blot hybridization (Figure 3-4,5-B,C). Taken together, the targeting 
vector and the corresponding ES cell clones for the conditional deletion of the 
Nfatc1 P1 promoter were proven to be intact for the conditional deletion and, 
therefore, suitable for the inactivation of P1 and P1-directed transcription. 
 
 
Figure 3-5 Confirmation of positive ES clones by Southern blot and 
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Cre recombinase treatment of mutated ES cells. 
 
Note the appearance of a rapidly moving band of 3.8 kb from the mutated 
allele of the Nfatc1 gene and a slowly migrating band of 14.7 kb from the 
wild type allele hybridized with a probe for the left arm (A and B). Bands of 
11.3 kb and 14.7 kb appeared upon hybridization with the right probe (as 
shown in C, lane 15). When Cre recombinase was expressed in the 
positive ES cells No. 15, the PGKneo fragment flanked by loxp sites was 
removed. The removal of bands of 4 kb (B) and 11.3 kb (C) upon Cre 
recombinase expression indicated the intactness of the targeted allele 
which is efficiently cut by Cre.  
 
 
3.1.6 Chimeras  
To get mutated mice carrying mutated Nfatc1 alleles for the conditional 
deletion of its promoters, the positive ES cell lines shown above were injected 
into murine blastocysts. But no germ line was detected in spite of extended 
efforts and dozens of chimeras (Figure 3-6) for unknown reason. 
 
 
Figure 3-6 Chimeras generated from ES cells carrying a targeted Nfatc1 
allele (black dots) in a host mouse (brown). 
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3.2 Analysis of NFATc1 Function in Chicken B cell Line DT40  
 
To explore NFATc1 function in a different system, we established collaboration 
with Dr. Eisaku Kondo (University of Okayama, Japan) for the inactivation of 
NFATc1 in  the chicken B cell line DT40. This cell line represents an effective 
alternative system for gene disruption experiments in somatic cells (Winding 
and Berchtold, 2001). In addition, DT40 B cells provide a versatile system to 
study molecular mechanisms controlling immunoreceptor-mediated apoptosis.    
3.2.1 Disruption of the Nfatc1 gene in chicken DT40 B lymphocytes and 
re-expression of human NFATc1/αΑ or αC 
To identify the function of different isoforms of Nfatc1, the DT40 B system has 
been used to inactivate the chicken endogenous Nfatc1 gene. Upon 
inactivation of endogenous Nfatc1 gene by Eisaku Kondo, he introduced 
plasmids encoding the human Nfatc1 isoforms Nfatc1/αA and Nfatc1/αC into 
NFATc1-/-/- DT40 cells to study the function of individual NFATc1 isoforms. To 
disrupt the endogenous Nfatc1 gene three rounds of inactivation had to be 
performed to destroy the three Nfatc1 alleles which are present in DT40 cells 
(Figure 3-7-A). By Southern blot hybridizations it was shown that indeed the 
three Nfatc1 alleles were inactivated, and by PCR and Western blots assays it 
was demonstrated that no NFATc1 protein was synthesized (Kondo et al., in 
prep.). Afterwards, upon transfection of expression vectors encoding the 
human Nfatc1/αΑ or Nfatc1/aC proteins these proteins were faithfully 
expressed in NFATc1-/-/- DT40 cells (Figure 3-7-B). These approaches and 
models provide the opportunity to study the function of individual NFATc1 
isoforms, especially of NFATc1/αΑ  wich differs remarkably from the other 
isoforms by its short C terminal peptide (Figure 1-1). 
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A 
 
Figure 3-7-A Inactivation of the chicken Nfatc1 gene in DT40 B cells: 
Scheme of targeting strategy (from Kondo et al., 2007, in preparation).  
Above, the locus of chromosomal chicken Nfatc1 gene is depicted including 
exons 5, 6, 7 and 8. Restriction sites are indicated for cleavage by Sac I (S), 
Bam HI (B) and Kpn I (K). The probe which was used for the Southern blot is 
shown by a black bar. Targeting vectors were constructed by the assembly of a 
resistance gene (blasticidin S, bsr; histidinol D, hisDr; puromycin, puror) with 
two chromosomal Nfatc1 DNA segments of 4.5 kb and 3.2 kb, respectively. 
Site-specific recombination resulted in the appearance of three targeted loci 
containing either the bsr and hisDr genes in the orientation of transcription, or 
the puror gene in the reversed orientation. 
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 B 
 
 
Figure 3-7-B Re-expression of human Nfatc1/αΑ or Nfatc1/αC in 
NFATc1-/-/- DT40 cells (from Kondo et al., 2007, in prep.). 
Expression of human chimeric Nfatc1/αΑ or Nfatc1/aC- EGFP (left part of B) 
or HA-tagged  fusion proteins (right part of B) in NFATc1-/-/- DT40 cells was 
shown by Western blot. 
 
3.2.2 Expression of human NFATc1/αΑ  or human NFATc1/αC and 
apoptosis induction 
Upon activation of the BCR by anti-IgM Ab, the induction of apoptosis was 
checked by FACS. When no NFATc1 isoform was expressed, apoptosis 
increased by 30% upon Ab stimulation. When NFATc1/αΑ was expressed, the 
apoptosis increased only slightly – or stayed the same - whereas expression of 
NFATc1/αC led to an increase to 23% compared to NFATc1-/-/- DT40 cells, and 
it increased 11 fold compared to cells expressing NFATc1/αA. This indicates 
that NFATc1/αΑ protects DT40 B cells against apoptosis while NFATc1/αC 
appears to enforce apoptosis (Figure 3-8). 
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Figure 3-8 NFATc1/αA  protects cells from apoptosis while NFATc1/αC 
exaggerates apoptosis, which is initiated by anti-IgM Ab directed 
against the BCR (from Kondo et al., 2007, in prep.). 
The apoptosis induction of NFATc1-deficient DT40 cells increased 30% (left 
panel); whereas expression of human NFATc1/αΑ rescued NFATc1-
deficient DT40 cells from apoptosis (middle column). Moreover, expression 
of  NFATc1 /αC increased apoptosis up to 37% (right column) upon 
activation of BCR.  
 
 
Next, we measured apoptosis induction in these manipulated DT40 cells 
by H2O2.  It was astonishing to see that induction of apoptosis by H2O2 
resulted in effects on apoptosis for NFATc1/αΑ  and NFATc1/αC that  
were exactly inverse (Figure 3-9) compared with anti-IgM Ab stimulation. 
H2O2 exerts a number of diverse effects which, maybe, affect many 
physiological processes and signaling pathways (Iwata et al., 1997; Kim et 
al., 2005; Velez-Pardo et al., 2002), and lead to these surprising results. 
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Figure 3-9 H2O2 treatment led to inverse effects on apoptosis induction of DT40 
cells with protection of cells expressing the long isoform NFATc1/αC while 
exaggerating apoptosis of cells expressing the short isoform NFATc1/αΑ. 
 (A) Treatment for short time but with high concentrations of H2O2. (B, C) Treatment 
for relatively longer time but with low concentrations of H2O2. 
3.2.3 The pkc-θ  promoter is a NFATc1/αA target  
The IL-2 promoter is well known to be bound and controlled by NFAT 
transcription factors (Jain et al., 1995; Serfling et al., 1995). To set a positive 
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control, the human short isoform NFATc1/αΑ expressed in transfected DT40 
cells was checked to bind to a probe from the IL-2 promoter. Electrophoretic 
Mobility Shift Assays (EMSA) (Figure 3-10) were repeated 3 times using 
nuclear proteins from the WT, NFATc1-/-/- and NFATc1-/-/αA DT40 cell lines.  
The murine IL-2 promoter’s distal NFAT binding-site was used as probe 
labeled by P32-ATP. It formed complexes with the hNfatc1/αΑ protein while no 
such complexes were formed using protein from DT40 WT and NFATc1-/-/-  
cells (Figure 3-10, lanes 1-4). Such a complex formation is much more 
stronger (Figure 3-10, lane 5) upon induction of NFATc1 with TPA+ionomycin 
than that without induction (Figure 3-10, lane 6), and it can be disrupted by an 
unlabeled excess of murine IL2-NFAT oligonucleotides (Figure 3-10, lane 7 
and 8) but not by mutated ones (Figure 3-10, lane 9 and 10). Furthermore, 
when a monoclonal Ab of NFATc1 was added, a larger, slowly migrating 
complex was formed leading to a super-shift (Figure 3-10, lane 11). So, this 
experiment clearly shows that NFATc1/αΑ binds to the IL-2 promoter and 
controls its activity.  
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Figure 3-10 Binding of NFATc1/αA in nuclear proteins from Nfatc1−/−/αΑ   DT40 
cells to the distal NFAT-site of the IL-2 promoter. 
In lanes 5-11, protein extracts from DT40 B cells in which human NFATc1/αA was 
expressed.  The cells in Lanes 6-11 were induced with TPA+ionomycin for 4 hrs 
while in lane 5 the cells remained untreated. To demonstrate NFATc1 in the major 
complex formed, a monoclonal antibody raised against NFATc1 was added to the 
EMSA assay. For competition, a five or fifty fold excess of unlabeled wild type 
(lanes 7 and 8) or mutated oligonucleotide (9 and 10) of murine IL2-NFAT/AP-1 site 
was added into the incubation mixture. Lanes 1-4: Controls of untransfected DT40 
cells lacking the formation of NFATc1/αΑ complexes.  
SC: super-shift complex; FP: free probe; IL2-NFATM: IL2-NFAT mutant. 
 
DNA microarray studies have shown that in NFATc1−/−/αΑ  DT40 B cells 
expressing ectopically human NFATc1/αΑ the pkc-θ gene is several fold 
stronger expressed as in wild type cells (E. Kondo et al., unpublished). PKC-θ 
is crucial for the life and death of lymphocytes (Altman and Villalba, 2002; 
Krappmann et al., 2001), and its promoter is conserved during evolution. As 
shown in Figure 3-11-A, the pkc-θ  promoter harbors a typical composite 
NFAT/AP-1 binding motif around nucleotide position -330. To test whether the 
pkc-θ promoter is really a target of NFATc1/αA in vitro, EMSA experiments 
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were done with nuclear protein from DT40 NFATc1-/-/αA cells, and from EL-4 T 
cells as controls. Both types of cells were induced with T+I for 4 hrs. The 
conserved NFAT sequence motif of chicken pkc-θ  promoter was labeled as 
probe. It formed one unique band (the first, faster running complex) with 
nuclear protein from DT40 NFAT− /− /αΑ cells, while one additional band (the 
second complex) - in addition to the previous one - was found in EL-4 T cells. 
The first complex was super-shifted by use of a monoclonal Ab raised against 
NFATc1 (Figure 3-11-B, lane 4 and 5), or was disrupted by a polyclonal Ab 
against NFATc1 (Figure 3-11-B, lane 17). Moreover, it was disassembled by 
an excess of NFAT-binding oligonucleotides from either the IL-2 promoter 
(Figure 3-11-B, lanes 8 and 9), and the human (Figure 3-11-B, lanes 10 
and11) or chicken pkc-θ  promoters (Figure 3-11-B, lanes 12 and 13), but 
remained unchanged in competitions using mutated oligonucleotides of 
chicken PKC-θ  promoter (Figure 3-11-B, lanes 14 and 15). In addition, it 
remained unaffected by unrelated Abs raised against Oct1 (Figure 3-11-B, lane 
3) or RelA/p65 (Figure 3-11-B, lanes 6 and 7). All these findings showed that 
the protein of the complex corresponds to NFATc1/αA  which bound to  the 
promoter of pkc-θ (and IL-2).  The protein of the second complex detected in 
EL-4 cell protein extracts corresponds to NFATc2 since this complex was 
found to be disrupted by a polyclonal Ab raised against NFATc2 (Figure 3-11-
B, lane 18). So, our results demonstrate the binding of NFATc1/αΑ to the pkc-
θ  promoter in vitro. 
To confirm that NFATc1/αΑ binds to the pkc-θ  promoter in vivo, chromatin 
immuno-precipitation experiments (CHIP) were done with DT40 WT, NFATc1-/-
/- and NFATc1-/-/αA cells. Cross-linked and sheared chromatin from these cells 
was immunoprecipitated using a human NFATc1 Ab after induction of cells 
with T+I. Upon precipitation and DNA extraction, fragments of pkc-θ promoter 
DNA were amplified by PCR with specific primers recognizing the pkc-θ  
promoter. These PCR amplifications resulted in fragments of the expected 
3. Results 
 - 54 - 
length of 320 bp (Figure 3-11-C). This demonstrates that human NFATc1/αΑ 
expressed in DT40 cells binds to the PKC-θ  promoter in vivo. 
 
Figure 3-11 The pkc-θ promoter is an NFATc1/αA target  
(A) A highly conserved composite NFAT+AP-1 sequence motif is located 
within the promoter region of chicken and human pkc-θ  genes. The core-
sequences of NFAT and AP-1 binding motifs are depicted in bold face 
letters.  
(B) Detection of NFATc1/αA binding to the NFAT site from the chicken pkc-
θ  promoter in EMSAs using nuclear protein extracts from NFATc1-/-/αA DT40 
B cells and EL-4 T cells induced by TPA+ionomycin for 4 hrs. An 
oligonucleotide probe of NFAT site (see Fig. 2-11-A) was incubated with 
nuclear proteins from NFATc1-/-/αA DT40 B cells (lanes 2-15) or EL-4 cells 
(16-18) in the absence (lanes 2 and 16) or presence of Abs specific for Oct1 
(lane 3), NFATc1 (lanes 4,5 and 17), NFATc2 (lane 18), p65/RelA (lane 6) 
or c-Rel (lane 7), or with a 5 (lanes 8, 10, 12 and 14) and 50 fold excess 
(lanes 9, 11, 13 and 15) of distal NFAT site of murine IL-2 promoter (lanes 8 
and 9), of a WT NFAT+AP-1 site from the human pkc-θ  promoter(lanes 10 
and 11), or of a WT (lanes 12 and 13) or mutated version (lanes 14 and 15) 
NFAT site from the chicken pkc-θ  promoter. In lane 1, the probe alone was 
fractionated. 
(C) In vivo interaction of NFATc1/αA protein with the chicken pkc-θ  
promoter. ChIP assay of WT, NFATc1-/-/- or NFATc1-/-/aA DT-40 B cells 
treated with TPA (20 ng/ml) + ionomycin (0.5 µM) (T+I) for 4 hrs was done. 
Chromatin was immunoprecipitated by a polyclonal Ab raised against 
NFATc1. 10% of chromatin input was used as loading control (input). 
Unrelated Abs (GST 0.4ug/ul) immunoprecipitation was used as negative 
control. The predicted fragment of PCR should be 320bps. MM: molecular 
marker, 100bp ladder. 
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3.2.4 NFATc1/αΑ cooperates with NF-κB to regulate transcription of 
Nfatc1 in lymphocytes 
Activation of NF-κB induced by T cell receptor costimulation is mediated by 
PKC-θ (Coudronniere et al., 2000). While PKC-θ is an NFATc1 target (shown in 
3.2.3), we asked whether NF-κB is another target of NFATc1/αΑ. Or do these 
two transcription factors have reciprocal interactions? Several binding sites for 
transcription factors, as for NF-κB, NF-AT and CREB, are located within the 
NFATc1 promoter P1 (Figure 3-12-A)(Chuvpilo et al., 2002). To test whether 
NF-κB interacts indeed with the NFATc1 P1 promoter in vitro, EMSA 
experiments were done using nuclear extract from Jurkat T cells. The 
oligonucleotids named P1- κB from the Nfatc1 promoter P1 and the one named 
Ig- κB corresponding to a consensus κB from the immunoglobulin kappa light 
chain gene enhancer, carrying binding sites for NF-κB protein, were used as 
probes. These probes formed complexes with nuclear protein of Jurkat cells, 
especially after induction of cells with T+I (Figure 3-12-B, C).  T+I treatment of 
cells induces activation of Nfatc1 gene directly. So, the increased activity of NF- 
κB was indicated by much stronger complex formation whether with P1-κΒ or 
with Ig-κB, as a consequence of induction of Nfatc1, suggesting a cross-talk 
between these two transcription factors. Such complexes were disassembled 
by competition with an excess of cold oligonucleotides of P1-κΒ or Ig-κB 
(Figures 2-12-B, C, lanes 8,9, 12 and 13), but not by mutated ones (Figures 2-
12-B and C, lanes 10 and 11). Abs raised against NFATc1 and NFATc2 and 
oligonucleotides from the IL-2 promoter did not affect the complex formation. It 
is astonishing that Abs raised against NF-κΒ generated super-shift complex 
with the probe Ig-κΒ (Figure 3-12-C, lanes 16 and 17), whereas a very poor 
supershif was observed with the complex from the probe P1-kB (Figure 3-12-B, 
lanes 16 and 17). Taken together the reciprocal interaction between 
NFATc1/αΑ and NF-κB was demonstrated in vitro. 
 To confirm the binding of NF-κB protein to the Nfatc1 promoter P1 in vivo, 
CHIP assays were performed 3 times (Figure 3-12-D). EL-4 cells remained 
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uninduced or were induced by TPA+ionomycin for 1 or 4 hrs. After shearing and 
immuno-precipitation with the Abs raised against NF-κB p50 or p65 the nuclear 
DNA was prepared. The bound DNA was amplified by primers matching the 
Nfatc1 promoter P1. The length of the fragments of the Nfatc1 promoter P1 
from the PCR was consistent with the expected 500 bps, which indicates the 
two NF-κB proteins contribute to the complex formation.  The binding activity of 
NF-κB p50 was stronger upon induction for 1 hr while the activity of p65 was 
stronger upon induction for 4 hrs. The negative control showed that no P1-DNA 
was detected in complexes immunoprecipitated by the unrelated Ab: GST. 
These data demonstrate that NF-κB can bind to the NFATc1 P1-promoter in 
vivo. They suggest and further prove that NF-κΒ contributes to the induction of 
the NFATc1 P1 promoter upon activation of T cells.  
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Figure 3-12-A, B, C 
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Figure 3-12 NF-κB factors contribute to induction of Nfatc1 P1 promoter 
(A) A highly conserved binding site and its sequence for the binding of 
NF-κΒ , followed by other transcription factor binding sites, in the Nfatc1 
Promoter 1. 
(B) Detection of NF-κB binding to the Nfatc1 P1 promoter in induced or 
uninduced Jurkat T cells with EMSA and band-shift. There are two kinds 
complexes, of which the fast migrating may be from individual isoform protein of 
NF-κΒ while the slower one from isoform combination.  The complexes were 
much stronger upon induction by TPA+ionomycin for 4 hrs (lane 3) than without 
induction (lane 2). Such complexes were disrupted by polyclonal Ab raised 
against NF−κΒ (Lanes 16 and 17), or by an excess of oligonucleotides of P1-κΒ 
(lanes 8 and 9) or Ig−κΒ (lanes 12 and 13), but remained unchanged when 
incubated with Abs against NFATc1 or NFATc 2, or with mutated P1-κΒ oligos 
(lanes 10 and 11), or with wild type (Pu-bd, lanes 4 and 5) or mutated (Pu-bd 
mut, lanes 6 and 7) oligonucleotides from the IL-2 promoter. 
(C) Detection of NF-κB binding to immunoglobulin kappa light chain gene 
enhancer in induced or uninduced Jurkat T cells by EMSA. The result 
presented is similar to those in (B) except that when the Ab against NF-κΒ was 
applied, larger complexes were formed and super-shifted (Lane 16 and 17), and 
no double complexes. 
(D) In vivo interaction of NF-κB protein with the murine Nfatc1 Promoter 
P1. ChIP assay of EL-4 T cells treated with TPA (20 ng/ml) + ionomycin (0.5 
µM) (T+I) for 4hrs. Chromatin was immuno-precipitated by antibodies raised 
against p50 & p65. The predicted fragment of PCR should be 500bps.  
P1-κB: oligonucleotides from Nfatc1 Promoter 1; Ig-κB: oligonucleotides from 
consensus immunoglobulin kappa light chain gene enhancer, both harboring 
binding sites for NF-κB protein 
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4. Discussion 
The central position of NFATc1 as a signaling integrator (Macian, 2005; 
Serfling et al., 2007) in controlling the life and death of lymphocytes prompted 
us to explore the function of six individual NFATc1 isoforms which show 
distinct differences in their spatial and temporal expression in lymphocytes. We 
found that the short isoform NFATc1/αA can protect B cells against apoptosis 
upon stimulation of cells through the BCR complex. And signaling pathways 
controlling NFATc1/αA and/or NF-κΒ  activation play an important role in 
apoptosis control. What are the molecular mechanisms controlling NFATc1/αA 
and/or NF-κΒ  activation in delaying or preventing apoptosis?  
4.1 The role of NFATc1 factors in the apoptosis induction of lymphocytes 
4.1.1 NFATc1/αΑ protects lymphocytes against apoptosis 
Previous studies have shown that NFAT factors contribute to survival of B cells 
(Fu et al., 2006), myocardiocytes (Pu et al., 2003), and osteoblasts (Van Sant 
et al., 2007). What are the mechanisms, which are controlled by the survival 
NFATc protein? Here, we have identified the short isoform NFAT1/αA as an 
anti-apoptotic factor in mature lymphocytes whereas the long isoform 
NFAT1/αC acts as a pro-apoptotic factor upon stimulation of BCR or TCR 
complexes (Figure 3-8). Upon stimulation of DT40 B cells with αIgM Ab, 
NFATc1/αA (and NFATc1/αC) was found to be translocated into the nucleus, 
thereby stimulating the expression of IL-2, a main factor of proliferation. 
However, numerous other genes are also activated by NFATc1/αA (and 
NFATc1/αC), including the Fas Ligand (FasL) gene. Previously, it has been 
shown that in mice double-deficient for NFATc2+c3, no FasL is formed upon 
stimulation, which might explain the strong defect in AICD induction of 
lymphocytes from such mice. These and further experimental data led us to 
conclude that – in contrast to NFATc1/αA - NFATc2+c3 exert a pro-apoptotic 
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function (Chuvpilo et al., 2002).   
  NFATc1 is a general integrator of signaling pathways and regulates the 
expression of many genes (Macian, 2005; Serfling et al., 2007), but individual 
NFATc1 isoforms appear to interact with different partners to initiate and to 
coordinate different gene expression programs. In normal B-cells, low grade 
malignant B lymphoma or B-cell non-Hodgkin lymphoma (NHL-B) cells, 
NFATc1 coordinates with NF-kB a B-lymphocyte stimulation (BLyS) pathway 
leading to survival and proliferation of B cells(Do et al., 2000; Fu et al., 2006). 
Two binding sites for NFAT and one for NF-kB factors were identified within the 
BLyS promoter. Abnormal BLyS signaling and NF-κB activity form a positive 
feedback loop which seems to be associated with lymphoma cell survival and 
proliferation (Fu et al., 2006). In cardiomyocytes, NFATc factors interact with 
numerous other transcription factors to balance between pro-apoptotic and anti-
apoptotic activities initiated by calcineurin activation (Asada et al., 1998; 
Jayaraman and Marks, 2000; Lotem et al., 1999; Wang et al., 1999; Zhao et al., 
1995). Such partners are AP-1, MEF2, and GATA4, each of which is integrated 
into its own cascades to which NFATc factors contribute (Pu et al., 2003).  
 In this study, we have identified NF-kB factors as “strong partners” for the 
NFATc1 short isoform NFATc1/αA upon induction of apoptosis in lymphocytes 
(Figure2-12). But for the H2O2-mediated apoptosis induction in DT40 B cells, 
the short isoform NFATc1/aA showed a pro-apoptotic activity while the long 
isoform NFATc1/aC acted in an anti-apoptotic manner. It is likely that differential 
factors and signaling pathways cause these surprising findings, such as FasL 
and MEK/ERK signaling (Devadas et al., 2002; Liu et al., 2006), protein kinase 
D (Zhang et al., 2005), the expression of the bcl-2 gene (Mao et al., 2001) and 
further events which might be needed to identify the synergy between partners 
of NFATc1 and corresponding signaling pathways. Our data appear to be 
consistent with published results that NFATc1 is a `moderate transcription 
factor` which needs other partners to facilitate its transcriptional function. 
Moreover, it is just this limitation of transcriptional capacity which leaves much 
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more `space` for other factors to join in and to lead to diverse consequences. 
So, it is not only one individual transcription factor to decide the final event but 
the net effect of involved transcription factors and other co-factors.  
4.1.2 NFATc1/αΑ cooperates with NF-kB to determine the fate of 
lymphocytes upon stimulation through immunoreceptors. 
NF-kB is a crucial transcription factor for lymphocyte activation, development, 
maturation, and apoptosis (Bours et al., 1992; Voll and Ghosh, 1999; Voll et 
al., 2000), and – if de-regulated – for lymphoma genesis (Patra et al., 2004). 
Upon stimulation of BCR or TCR complexes, the member of PKC family, 
PKCθ, is activated and then - via phosphorylation - stimulates IKK/NF-kB 
(Arendt et al., 2002) and IP3/Ca2+/calcineurin/NFAT(Pfeifhofer et al., 2003) 
signaling pathways, i.e. two signaling pathways which were not known to 
“cooperate”. Structurally, NF-κB and NFATc factors share homologous 
domains which are conserved between human and mouse, and – in the case 
of their similar DNA binding domains – lead to the binding to promoters of 
several common targeting genes. Thus, NFAT and NF-kB can recognize and 
control the expression of a set of target genes (Badran BM et al., 2002; 
Macian, 2005; Serfling et al., 2004). In this study, the PKCθ promoter was 
detected as a target of NFAT1/αA in vitro and in vivo (E. Kondo et al., 
unpublished). Thus, in addition to auto-regulation of NFATc1 gene (Asagiri et 
al., 2005; Chuvpilo et al., 2002), the PKCθ and NFAT1/αA form a positive 
feedback loop, and – as a result - the activation of NFATc1 becomes amplified. 
Consequently, NF-kB - as a putative downstream substrate of NFAT - is also 
amplified. In addition, activated calcineurin can also increase the activity of NF-
κB via several other mechanisms, such as by its immediate effect on the 
phosphorylation and degration of IκΒα, thereby leading to increased levels of 
active nuclear NF-κΒ (Jain et al., 1995). And in this study, the NFATc1 
promoter was shown to harbor binding sites for NF-κB to which NF-kB can 
bind in vitro and in vivo (Figure 3-12). As a consequence, the transcriptional 
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activity of Nfatc1 was up-regulated by NF-κB (E. Kondo et al., unpublished).  
 Interleukin 2 (IL-2) is an important lymphokine which is required for the 
processes of T cell activation, proliferation, clonal expansion and differentiation 
(Jain et al., 1995). Its promoter is one prominent target for NFAT transcription 
factors. The IL-2 promoter harbors two high-affinity and several low-affinity 
NFAT-binding sites, and several binding sites for NF-κB (Kang et al., 1992; 
Zhang and Nabel, 1994). In addition, several other factors, such as for AP-1, 
early growth response factors (EGR) and octamer binding factors (Oct) can 
bind to and control the IL-2 promoter (Macian, 2005; Serfling et al., 1995). 
These transcription factors can form composite complexes together with their 
targeting promoter sequence (Macian, 2005). 
 In summary, these two transcription factors, NFATs and NF-κBs, 
synergize via multiple interactions leading to the stimulation of early upstream 
initiator PKCθ and of downstream target gene promoters, such as the IL-2 
promoter (Figure 4-1). But the direct reciprocal transcriptional up-regulation 
between NF-κB and NFATc1 remains to be elucidated. The collaboration 
between these two signaling pathways together drives cells to proliferate and 
to be resistant against AICD, which is in line with the NF-κB's pro-survivable 
properties (Serfling et al., 2004; Voll et al., 2000). We further speculate that 
upon stimulation, NFATc1, as a balancer between life and death of 
lymphocytes, can form and shape the platform for its partner, i.e. of other 
transcription factor(s) as executor(s). However, how these partners of NFATc1 
are selected, how they control the decision between life or death of 
lymphocytes are unknown and deserve further experimental work.  
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Figure 4-1 Nfatc1/αΑ cooperates with NF-κΒ  to regulate gene expression in 
   lymphocytes 
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4.2 Experimental models for the conditional disruption of the 
Nfatc1 gene  
To conditionally delete NFATc1 in vivo, we modified ES cells (Figure 3-5, 6) by 
electroporation with a targeting vector for the site-specific integration into the 
Nfatc1 gene (Figure 3-4). The targeting vector was constructed by Dr. Jiming 
Liu using conventional DNA cloning strategies. In future, we will simplify and 
shorten the process of building targeting constructs by using a new strategy 
using ET recombination (Angrand et al., 1999). Such recombination ensures a 
rapid creation of vectors carrying mutations flanked by short synthesized 
homologous arms of the targeting gene and the corresponding BAC DNA in E. 
coli, thereby avoiding the tedious work of multiple rounds of digestion, ligation, 
transformation and DNA sequencing. In our targeting vectors, the P1 and P2 
promoters of Nfatc1 are flanked by loxp sites which allow the deletion of these 
DNA segments by Cre recombinase treatment in vitro and in vivo in the wild 
type locus of one allele (Fig 2-5 B and C). Unfortunately, in our experiments 
such a targeted Nfatc1 allele (Fig 2-6) could not be transmitted to the germ 
line. Currently, we do not know the reason for this failure. It could be due to the 
loss of pluripotency of ES cells which we used, or our handling of the ES cells. 
An emerging technique called laser-assisted injection may be a powerful 
solution to circumvent this dilemma (Poueymirou et al., 2007). It not only 
enforces the production of germ line transmission, but also makes possible 
early phenotype analysis with F0 chimeras which derived from ES cells with 
90% germ line transmission. 
 Other choices also affect the germ line transmission. Thus, 
contaminations with bacteria, fungi, yeast or mycoplasma can also block germ 
line transmission (Cobo et al., 2007). 
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4.3 The significance of this study 
 
In this study, the inducible short isoform of NFATc1, NFATc1/αA, was found to 
protect lymphocytes against apoptosis whereas the long isoform, NFATc1/αC, 
appears to facilitate apoptosis. NFATc1/αA and NF-κB were found to cross-
talk in the transcriptional upregulation of their target genes, such as the IL-2 
gene and – controled by a positive feed-back loop- the Nfatc1 gene itself, at 
multiple steps upon induction of apoptosis. While the pro-apoptotic mechanism 
of NFATc1`s long isoform(s) remains unclear, its corresponding “death 
partners” are worth for further studies. From previous investigations, the 
transcription factor Egr might be one promising candidate of such “death 
partners” (Rengarajan et al., 2000).  
 Apoptosis determines the involved lymphocytes to live or to die. The 
elucidation of functional roles of NFATc1`s short or long isoforms in the control 
of apoptosis of lymphocytes helps to understand apoptosis regulation, and 
thereby, the fate of lymphocytes. This is a key mechanism for the generation of 
autoimmunity, immune deficiencies, leukemias and lymphomas, which affect 
millions of people all over the world. Moreover, the cross-talk pattern – i.e. how 
NFATc1`s isoforms and their partners synergize - also indicates a valuable 
approach to study how the individual NFATc1 isoforms (and other NFATc 
members) cross-talk with their transcriptional partners in other cells or organs 
at the molecular level, such as in cardiomyocytes during heart failure 
(Diedrichs et al., 2004; Phoon et al., 2004). Since the different NFATc1 
isoforms have distinct functions, it will be necessary to develop 
individual Abs raised against these isoforms for basic research and, in a next 
step, for therapeutic purposes. So, the main finding of our work, i.e. the anti-
apoptotic role of NFATc1/αA and its cross-talk with NF-κB, confirmed former 
studies of this laboratory and prompted us to go further. 
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Summary 
 
Functional Role of NFATc1 in the Control of Life and 
Death of Lymphocytes 
Wen Chen 
B and T lymphocytes are the central cells of the adaptive immune system. 
Among the events of lymphocyte development, the expression of immune T 
and B cell receptors (TCR, BCR) and of their signal transduction components 
are crucially involved in the maturation of lymphocytes. Of the signaling 
pathways emerging from the TCR and BCR complexes, the NFAT and NF-kB 
signaling cascades upon apoptosis induction are in the centre of signaling 
events which direct lymphocyte fate. NFATs play diverse functions in 
apoptosis. We have previously observed that NFATc2 and c3 support the 
apoptosis of effector T cells, and, therefore, exert a pro-apoptotic function in T 
lymphocytes. In contrast, in these studies the function of NFATc1/αA remained 
unclear. In this study,  murine ES cells and DT40 B cells were used in parallel 
to disrupt the Nfatc1 gene and to study the function of individual 6 Nfatc1 
isoforms, especially the function of highly inducible NFATc1/αA.  
We found that the short isoform NFATc1/αA protects DT40 B cells 
against apoptosis while the long isoform NFATc1/αC appears to enforce 
apoptosis. DNA microarray studies have shown that in NFATc1−/−/αΑ  DT40 B 
cells expressing ectopically human NFATc1/αA, the pkc-θ gene is several fold 
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stronger expressed as in wild type cells. Our results of EMSA (Electrophoretic 
Mobility Shift Assays) and ChIP (chromatin immuno-precipitation) experiments 
demonstrated the binding of NFATc1/αA to the pkc-θ  promoter in vitro and in 
vivo. NF-κB was also found to bind to the NFATc1 P1-promoter in vitro and in 
vivo. These data suggest and further prove that NF-κB contributes to the 
induction of the NFATc1 P1 promoter upon activation of T cells. So, 
NFATc1/αA and NF-κB were found to cross-talk in the transcriptional 
upregulation of their target genes, such as the IL-2 gene and the Nfatc1 gene 
itself, at multiple steps upon induction of apoptosis. While the pro-apoptotic 
mechanism of NFATc1`s long isoform(s) remains unclear, its corresponding 
“death partners” are worth further studies. The elucidation of functional roles of 
NFATc1`s short or long isoforms in the control of apoptosis of lymphocytes 
helps to understand apoptosis regulation, and thereby, the fate of lymphocytes. 
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Zusammenfassung 
 
Die Funktionelle Rolle von NFATc1 in der Kontrolle 
von Leben und Tod von Lymphozyten 
Wen Chen 
 
Die B und T Lymphozyten sind von zentraler Bedeutung für das adaptive 
Immunsystem. Während der Lymphozytenentwicklung ist die Expression von T 
und B Zellrezeptoren (TCR, BCR) und ihrer Signalstransduktionskomponenten 
im Reifungsprozeß der Lymphozyten von entscheidender Bedeutung. Von den 
vom TCR und BCR Komplex ausgehenden Signalwegen sind die NFAT und 
die NF-κB Signalskaskaden, mit der Kontrolle der Apoptoseinduktion, zentrale 
Ereignisse des Lymphozytenschicksals. NFAT´s spielen unterschiedliche 
Rollen in der Apoptose.  In vorausgehenden Experimenten konnten wir zeigen, 
daß NFATc2 und c3 die Apoptose von Effektor T Zellen unterstützen, und 
somit weisen sie eine pro-apoptotische Funktion in T Lymphozyten auf. Die 
Funktion von NFATc1/aA blieb jedoch ungeklärt. In der vorliegenden Studie 
wurden ES Zellen von der Maus und DT40 B Zellen vom Huhn verwendet, um 
paralell das Nfatc1 auszuknocken und die Rolle der einzelnen 6 Nfatc1 
Isoformen zu studieren, insbesorndere die Funktion des stark induzierbaren 
NFATc1/αA. 
Wir konnten feststellen, daß die kurze Isoform NFATc1/αΑ DT40 B Zellen 
gegen Apoptose schützt, während die lange Isoform NFATc1/αC scheinbar die 
Apoptose verstärkt. DNA Microarray Studien haben gezeigt, daß NFATc1-/-/αA 
DT40 B Zellen, die humanes NFATc1/αA ektopisch exprimieren, das pkc−θ  
Gen deutlich stärker exprimieren als in Wildtyp Zellen. Unsere Ergebnisse von 
EMSA und ChIP Experimenten demonstrieren die Bindung von NFATc1/αA an 
den pkc-θ Promoter in vitro und in vivo. Für NF-κB wurde eine Bindung am 
Nfatc1 P1 Promoter in vitro und in vivo gezeigt. Dies lässt vermuten, daß NF-
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κB eine Rolle bei der Induktion am Nfatc1 P1 Promoter nach der Aktivierung 
der T Zelle spielt.  
Es wurde herausgefunden, daß nach Induktion der Apoptose, NFATc1/αA und 
NF-κB „cross-talk“ an unterschiedlichen Stellen in der transkriptionellen 
Hochregulierung ihrer Zielgene, wie z.b. dem IL-2 Gen und dem Nfatc1 Gen 
selbst. Weil die pro-apoptotischen Mechanismen der lange(n) Isoform(en) von 
NFATc1 unklar bleiben, sollten die korrespondierenden „death partners“ in 
weiteren Studien untersucht werden. Eine Klärung der funktionellen Rollen der 
NFATc1 Isoformen in der Kontrolle der Apotose in Lymphozyten wird helfen, 
die Regulation der Apotose, und damit auch das Schicksal der Lymphozyten, 
zu verstehen.  
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μg   microgram   
μl   microliter   
μm   micrometer   
aa   amino acid   
AID   auto-inhibitory domain   
AP-1   activation protein-1   
APS   ammonium persulfate   
BSA   bovine serum albumin               
CaM   calmodulin   
CaN   calcineurin   
CD   cluster of differentiation  
ChIP   chromatin immuno-precipitation    
CHX   cyclohexamide   
CLP   common lymphoid precursor  
CnA   calcineurin A  
CnB   calcineurin B   
CPM   counts per minute 
CREB  cAMP response element binding  
CsA   cyclosporin A  
Ct   threshold cycle   
DEPC  diethylpyrocarbonate   
DKO   double knockout   
DMSO  dimethyl sulfoxide   
DN   double negative   
DNA   deoxyribonucleic acid   
dNTPs  deoxynucleotide triphosphates   
DP   double positive    
DSBs  double strand breaks    
ECL   enhanced chemical lumiscence  
EDTA  ethylenediaminetetraacetic acid   
EGTA  ethyleneglycotetraacetic acid                                                                                                        
EMSA  electrophoretic mobility shift assay  
ERK   extracellular signal-regulated kinase   
FACS  fluorescence activated cell sorting  
FCS   fetal calf serum   
FKBP  FK506 binding protein  
GAPDH  glyceraldehyde 3-phosphate dehydrogenase   
GSK3  glycogen synthase-3 kinase   
GST   glutathione-S-transferase    
HGNC  the gene nomenclature committee of the human genome 
organization  
HIV   human immunodeficiency virus 
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HPRT  hypoxanthine phosphoribosyltransferase  
HSCs  hematopoietic stem cells   
HUGO  the human genome organization   
IL   interleukin  
IMGT  immunogenetics  
IPTG  isopropyl-ß-D-thiogalactopyranoside                                                                                     
JNK   c-Jun N-terminal kinase   
LT-HSCs  long-term HSCs  
mA   milliampere   
MAPK  mitogen-activated protein kinase   
MEK   MAP kinase/ERK kinase   
MEKK  MEK kinase  
mg   milligram   
MHC  major histocompatibility complex   
mm   millimeter   
mM   millimolar   
MPP   multi-potent progenitor  
mRNA  messenger ribonucleic acid   
NFAT  nuclear factor of activated T cells   
ng   nanogram   
RR   NFAT regulatory region  
OD   optical density  
PAGE  polyacrylamide gel electrophoresis   
PBS   phosphate buffered saline   
PCI   phenol:chloroform:isoamyl alcohol   
PCR   polymerase chain reaction   
PMSF  phenylmethylsulfonyl fluoride                                                                                                      
poly(dI·dC) poly(deoxyinosine·deoxycytosine)                                                                                             
pre-TCR  pre-T cell receptor   
qPCR  quantitative PCR   
RNA   ribonucleic acid   
rpm   revolution per minute   
RSD   Rel/NF-κB similarity domain 
RSSs  recombination signal sequences   
RT    room temperature; reverse transcription   
RT-PCR  reverse transcription polymerase chain reaction  
SCID  severe combined immunodeficiency  
SDS   sodium dodecyl sulphate   
SP   single positive    
TAD   trans-activation domain    
TBS   tris-buffered saline  
TCR   T cell receptor   
TEMED  tetramethylethylenediamine                                                                                                          
TPA   12-O-tetradecanoyl phorbol 13-acetate   
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Treg   regulatory T cell    
WT   wild-type
ZAP-70  ζ-associated protein of 70 kD 
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